<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.0 20040830//EN" "journalpublishing.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="2.0" xml:lang="en" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">JMIR Form Res</journal-id><journal-id journal-id-type="publisher-id">formative</journal-id><journal-id journal-id-type="index">27</journal-id><journal-title>JMIR Formative Research</journal-title><abbrev-journal-title>JMIR Form Res</abbrev-journal-title><issn pub-type="epub">2561-326X</issn><publisher><publisher-name>JMIR Publications</publisher-name><publisher-loc>Toronto, Canada</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">v10i1e78563</article-id><article-id pub-id-type="doi">10.2196/78563</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Paper</subject></subj-group></article-categories><title-group><article-title>COVID-19 Knowledge, Attitudes, and Practices and Perceived Risk: Cross-Sectional Mixed Methods Study</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" equal-contrib="yes"><name name-style="western"><surname>Ben-Zacharia</surname><given-names>Aliza Bitton</given-names></name><degrees>DNP, PhD</degrees><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">*</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Ben-Zacharia</surname><given-names>Moshe</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Smrtka</surname><given-names>Jennifer</given-names></name><degrees>MSN</degrees></contrib></contrib-group><aff id="aff1"><institution>Department of Nursing, Hunter College Bellevue School of Nursing</institution><addr-line>60 West Street</addr-line><addr-line>New York</addr-line><addr-line>NY</addr-line><country>United States</country></aff><aff id="aff2"><institution>Department of Virtual Reality, The Body VR LLC</institution><addr-line>New York</addr-line><addr-line>NY</addr-line><country>United States</country></aff><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Mavragani</surname><given-names>Amaryllis</given-names></name></contrib><contrib contrib-type="editor"><name name-style="western"><surname>Steenstra</surname><given-names>Ivan</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name name-style="western"><surname>Asut</surname><given-names>Ozen</given-names></name></contrib><contrib contrib-type="reviewer"><name name-style="western"><surname>Sujarwoto</surname><given-names>Sujarwoto</given-names></name></contrib><contrib contrib-type="reviewer"><name name-style="western"><surname>Sikder</surname><given-names>Tajuddin</given-names></name></contrib></contrib-group><author-notes><corresp>Correspondence to Aliza Bitton Ben-Zacharia, DNP, PhD, Department of Nursing, Hunter College Bellevue School of Nursing, 60 West Street, New York, NY, 10006, United States, 646-226-2616; <email>abenzacharia@gmail.com</email></corresp><fn fn-type="equal" id="equal-contrib1"><label>*</label><p>these authors contributed equally</p></fn></author-notes><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>19</day><month>5</month><year>2026</year></pub-date><volume>10</volume><elocation-id>e78563</elocation-id><history><date date-type="received"><day>11</day><month>06</month><year>2025</year></date><date date-type="rev-recd"><day>13</day><month>03</month><year>2026</year></date><date date-type="accepted"><day>24</day><month>03</month><year>2026</year></date></history><copyright-statement>&#x00A9; Aliza Ben-Zacharia, Moshe Ben-Zacharia, Jennifer Smrtka. Originally published in JMIR Formative Research (<ext-link ext-link-type="uri" xlink:href="https://formative.jmir.org">https://formative.jmir.org</ext-link>), 19.5.2026. </copyright-statement><copyright-year>2026</copyright-year><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Formative Research, is properly cited. The complete bibliographic information, a link to the original publication on <ext-link ext-link-type="uri" xlink:href="https://formative.jmir.org">https://formative.jmir.org</ext-link>, as well as this copyright and license information must be included.</p></license><self-uri xlink:type="simple" xlink:href="https://formative.jmir.org/2026/1/e78563"/><abstract><sec><title>Background</title><p>The COVID-19 pandemic was marked by rapidly evolving and inconsistent public health messaging, contributing to confusion regarding recommended preventive behaviors. Knowledge, attitudes, and practices (KAP) and perceived risk frameworks offer a structured approach to examine how education, personal beliefs, and contextual factors influence health behaviors during public health emergencies. Vulnerable populations, such as patients with multiple sclerosis (MS), experience heightened risk perception compared with the general population, which may further shape behavioral responses.</p></sec><sec><title>Objective</title><p>This study aimed to examine COVID-19&#x2013;related KAP and perceived risk among patients with MS, health care providers, and laypeople during the first 6 months of the pandemic. The aim of mixed methods was to explore quantitative factors associated with KAP and perceived risk and to qualitatively describe participants&#x2019; perceptions and emotional responses to the pandemic.</p></sec><sec sec-type="methods"><title>Methods</title><p>A descriptive, cross-sectional, partially mixed methods explanatory sequential design was used. Participants were recruited using convenience sampling and completed an online demographic questionnaire and a COVID-19 KAP instrument that included perceived risk items. Quantitative data were analyzed using descriptive statistics and inferential analyses to examine group differences and associations between perceived risk and preventive behaviors. Chi-square testing was applied to compare perceived risk across groups, and correlational analyses were used to examine the relationships between perceived risk and behavioral practices. Qualitative comments provided by participants were analyzed using thematic analysis to further contextualize quantitative findings and to explore perceived risk experiences.</p></sec><sec sec-type="results"><title>Results</title><p>A total of 148 participants were included, comprising 43 (29%) individuals with MS, 50 (33.8%) health care providers, and 55 (37.2%) laypeople. Overall, 90% (n=133) of participants demonstrated basic knowledge of COVID-19 transmission and prevention. Attitudes toward public health guidance and self-reported preventive behaviors varied across groups. Lay participants most frequently reported a moderate perceived risk of COVID-19 infection, whereas participants with MS and health care providers more commonly reported high perceived risk (<italic>&#x03C7;</italic>&#x00B2;<sub>6</sub>=12.65, <italic>P</italic>=.049). Neither immunosuppressive treatment status nor vaccine hesitancy significantly predicted perceived risk. However, higher perceived risk was significantly associated with greater avoidance of crowded and public places. Qualitative analysis yielded 5 interrelated themes describing participants&#x2019; perceived risk experiences: uncertainty related to evolving scientific information; anxiety regarding personal and family safety; fear of infection and long-term consequences; vulnerability, particularly among individuals with chronic illness and frontline exposure; and accountability toward protecting others through adherence to preventive measures. These themes provided contextual insight into the emotional and cognitive processes underlying reported attitudes and behaviors.</p></sec><sec sec-type="conclusions"><title>Conclusions</title><p>Knowledge of COVID-19 is associated with favorable attitudes and engagement in preventive practices across populations. Differences in perceived risk highlight the importance of tailoring risk communication and educational strategies to specific populations. KAP-focused educational interventions that explicitly address uncertainty, emotional responses, and behavioral translation may strengthen preparedness and promote sustained protective behaviors during future public health emergencies.</p></sec><sec><title>Trial Registration</title><p>ClinicalTrials.gov NCT07021716; https://clinicaltrials.gov/ct2/show/NCT07021716</p></sec></abstract><kwd-group><kwd>COVID-19</kwd><kwd>knowledge</kwd><kwd>attitudes</kwd><kwd>practices</kwd><kwd>percieved risk</kwd></kwd-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>COVID-19, caused by the spread of coronavirus through respiratory droplets [<xref ref-type="bibr" rid="ref1">1</xref>], has evolved into a pandemic, leading to rapidly changing public health messages and precautions. This has resulted in confusion among patients with chronic illnesses, health care professionals, and the public. Multiple sclerosis (MS), an autoimmune disease affecting the central nervous system, may worsen with COVID-19 [<xref ref-type="bibr" rid="ref2">2</xref>-<xref ref-type="bibr" rid="ref7">7</xref>], as patients with MS are more vulnerable to infection due to their immunosuppressive or immunomodulatory treatments [<xref ref-type="bibr" rid="ref2">2</xref>-<xref ref-type="bibr" rid="ref7">7</xref>].</p><p>Recent evidence highlights that knowledge, attitudes, and practices (KAP) during the COVID-19 pandemic critically influenced adherence to preventive behaviors and public health recommendations. Across diverse populations, adequate knowledge of COVID-19 transmission and prevention has been consistently associated with more positive attitudes and greater compliance with protective measures such as mask use, hand hygiene, and social distancing [<xref ref-type="bibr" rid="ref8">8</xref>-<xref ref-type="bibr" rid="ref10">10</xref>]. However, gaps between knowledge and practice remain prevalent, particularly in dynamic public health contexts. For example, cross-sectional studies among health care workers, university students, and community populations report high awareness levels&#x2014;2318 (91.2%) [<xref ref-type="bibr" rid="ref11">11</xref>] of participants recognized COVID-19 as an acute viral infection, and 2540 (99.95%) [15] correctly identified wearing masks as protective&#x2014;yet adherence to recommended practices varied considerably [<xref ref-type="bibr" rid="ref11">11</xref>-<xref ref-type="bibr" rid="ref15">15</xref>]. Systematic reviews indicated that demographic factors, including age, education, occupation, urban residence, and access to reliable health information, significantly shape KAP outcomes. Bekele et al [<xref ref-type="bibr" rid="ref16">16</xref>] in a systematic review of multiple cross sectional studies, reported that knowledge levels ranged from 40% to 99.5%, positive attitudes from 70% to 97.1%, and wide variation in practices, with determinants including education, occupation, income, gender, age, residence, work experience, media access, and marital status. Similarly, Rehman et al [<xref ref-type="bibr" rid="ref17">17</xref>] found that 250 (65%) of comorbid patients demonstrated good knowledge, 219 (57%) had positive attitudes, and 196 (51%) adhered to recommended practices, with factors such as educational status (odds ratio [OR] 3.2, 95% CI 2.79&#x2010;3.58), occupation (OR 3.65, 95% CI 3.31&#x2010;4.25), urban residence (OR 2.43, 95% CI 1.65&#x2010;3.02), financial status (OR 4.02, 95% CI 3.66&#x2010;4.38), and information sources (OR 2.64, 95% CI 2.19&#x2010;3.26) significantly influencing outcomes.</p><p>These findings underscore the persistent variability in translating knowledge into preventive actions, highlighting the need for tailored public health strategies. Even in populations with high awareness and positive attitudes, practice gaps remain, emphasizing that KAP is not uniform across demographic and socioeconomic groups. Quantitative evidence demonstrates that interventions targeting education, information accessibility, and context-specific risk communication are essential to strengthen compliance with preventive measures. Moreover, continuous monitoring of KAP across different population subgroups and epidemic stages is critical for refining public health education, particularly for vulnerable groups such as patients with comorbidities, where tailored messaging can improve preventive behaviors and reduce COVID-19&#x2013;related morbidity [<xref ref-type="bibr" rid="ref11">11</xref>,<xref ref-type="bibr" rid="ref16">16</xref>,<xref ref-type="bibr" rid="ref17">17</xref>].</p><p>Studies on MS have shown variable results. The risk of COVID-19 in patients with MS was influenced by their knowledge, attitudes, and behaviors. Studies show that most of the patients with MS are well-informed and have good attitudes toward COVID-19 prevention, but health education programs remain essential [<xref ref-type="bibr" rid="ref18">18</xref>]. Sahraian et al [<xref ref-type="bibr" rid="ref19">19</xref>] found that 210 (90%) of patients with MS understood the importance of gloves and masks, though only 170 (73%) fully followed quarantine rules. Some patients still attended social events (n=40, 17%) and visited crowded places (n=65, 28%) [<xref ref-type="bibr" rid="ref19">19</xref>]. Both laypeople and health care providers worldwide had a good understanding of COVID-19, with awareness among US public largely driven by Centers for Disease Control and Prevention (CDC) information through social media.</p><p>Most studies addressed 1 group of people, health care professionals [<xref ref-type="bibr" rid="ref20">20</xref>-<xref ref-type="bibr" rid="ref24">24</xref>], the public or laypeople [<xref ref-type="bibr" rid="ref25">25</xref>-<xref ref-type="bibr" rid="ref32">32</xref>], or patients with chronic illness [<xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref33">33</xref>]. Our study is unique as it compared the KAP of the 3 groups, health care professionals, laypeople or the public, and patients with chronic illness, which may contribute to the educational, attitudinal, and behavioral needs of each group. The aim of this study was to examine COVID-19&#x2013;related KAP among health care professionals, laypeople, and individuals with MS during the first 6 months of the pandemic. Specifically, this study sought to (1) compare perceived risk of COVID-19 across these 3 groups and (2) explore qualitative themes reflecting participants&#x2019; perceptions and emotional responses to COVID-19 risk. By examining these groups concurrently, this study aimed to provide insights that may inform targeted education and risk communication strategies for diverse populations during future public health emergencies.</p></sec><sec id="s2" sec-type="methods"><title>Methods</title><sec id="s2-1"><title>Design</title><p>This is a descriptive, cross-sectional, partially mixed methods explanatory sequential study, following the Good Reporting of a Mixed Methods Study (GRAMMS) guideline. This study concentrated on the KAP of patients with MS, health care professionals, and laypeople. The aim was to explain the quantitative survey results with qualitative themes in an explanatory sequential design. The goal of the quantitative phase was to examine the COVID-19&#x2013;related KAP among health care professionals, laypeople, and patients with MS during the first 6 months of the pandemic and to compare the perceived risk of coronavirus infection across these 3 groups. The goal of the qualitative phase of this study was to identify and analyze the emergent themes reflecting participants&#x2019; perceptions of their risk related to COVID-19. The goal of the mixed methods phase was to generate integrated support for the participants&#x2019; KAP and perceived risk based on quantitative and qualitative evidence.</p></sec><sec id="s2-2"><title>Ethical Considerations</title><p>Ethical approval for this study was obtained from the institutional review board (IRB) of the City University of New York, Hunter College, Human Research Protection Program (IRB File 2020&#x2010;0299). A research consent information form was attached to the online surveys. It described the voluntary nature of the survey and participants&#x2019; right to withdraw at any time and omit answers to any of the questions. Participation after reading the information sheet constituted evidence of consent. IRB exemption was provided for this study of 148 participants aged 18 years and older, including 118 (79.7%) female participants and 27 (18.2%) male participants. No compensation was provided to participants. We have adhered to local, national, regional, and international law and regulations regarding protection of personal information, privacy, and human rights. This study was approved by the University Integrated IRB and registered at ClinicalTrials.gov (identifier: NCT07021716).</p></sec><sec id="s2-3"><title>Theoretical Framework</title><p>The knowledge-attitude-behavior (KAB) model considers that knowledge and information gained are fundamental prerequisite for behavioral changes. People are able to gain knowledge and practical skills through education. Accordingly, professionals, laypeople, and patients need to learn and get basic and advanced knowledge that can lead to the growth of positive beliefs and attitudes fortified with the acceptance of healthy behaviors [<xref ref-type="bibr" rid="ref34">34</xref>,<xref ref-type="bibr" rid="ref35">35</xref>]. Furthermore, the KAB framework highlights the relationship between knowledge, attitudes, and behaviors and their influence on actions [<xref ref-type="bibr" rid="ref36">36</xref>].</p></sec><sec id="s2-4"><title>Instruments</title><p>The KAP instrument consisted of a demographic form and a KAP questionnaire. The prequestionnaire solicited basic demographic information, such as the participant&#x2019;s age, gender, education level, and patients&#x2019; disease-related information. The KAP instrument was adapted from the CDC [<xref ref-type="bibr" rid="ref37">37</xref>,<xref ref-type="bibr" rid="ref38">38</xref>] and a previously validated Ebola KAP survey under CDC guidance with permission. Ebola-specific items were removed, and the remaining items were modified to reflect COVID-19 epidemiology, transmission routes, and recommended preventive behaviors during the early phase of the pandemic. The core KAP domains (KAP and perceived risk) were retained, and the adapted instrument was reviewed for content relevance prior to administration. The KAP survey instrument has been used nationally and internationally to explore people&#x2019;s health behaviors and their lifestyle changes [<xref ref-type="bibr" rid="ref26">26</xref>,<xref ref-type="bibr" rid="ref30">30</xref>,<xref ref-type="bibr" rid="ref32">32</xref>,<xref ref-type="bibr" rid="ref38">38</xref>,<xref ref-type="bibr" rid="ref39">39</xref>]. The survey included 50 close- and open-ended questions that took 20 to 25 minutes to complete. It covered demographics (10 items), COVID-19 knowledge (15 items), attitudes (17 items), and practices (8 items). True or false questions had &#x201C;I don&#x2019;t know&#x201D; and &#x201C;declined to answer&#x201D; options, with responses categorized as correct or incorrect [<xref ref-type="bibr" rid="ref40">40</xref>,<xref ref-type="bibr" rid="ref41">41</xref>]. Open-ended questions were analyzed to assess the participants&#x2019; perceptions qualitatively.</p><p>Perceived risk for contracting COVID-19 was assessed using a 5-point scale (0=no risk at all, 1=small risk, 2=moderate risk, 3=high risk, and 4=don&#x2019;t know). Perceived risk of COVID-19 was assessed as a categorical variable. It was analyzed as dichotomous variable (low risk vs moderate-t0-high risk) and as 4-categorical variable (low risk, moderate risk, high risk, and don&#x2019;t know). Perceived risk was assessed and analyzed in each group, comprising patients with MS, health care professionals, and laypeople.</p></sec><sec id="s2-5"><title>Data Collection</title><p>The population for this study included health care professionals (nurses and physicians), patients with MS, and laypeople from the northeast region in the United States. It included participants from New York, Connecticut, and Massachusetts. A convenience sampling approach was used to enhance recruitment. The participants were recruited using blast emails through health centers, MS centers, and community resources. Data were collected via an online self-reported questionnaire from April 2020 to September 2020. The surveys were completed online using anonymous and confidential software, that is, a &#x201C;Monkey&#x201D; survey. The inclusion criteria of the study included adult people (&#x2265;18 y), consisting of patients with MS, health care professionals (nurses and physicians), and adult laypeople. The study did not include any exclusion criteria.</p></sec><sec id="s2-6"><title>Data Analysis</title><p>Descriptive analyses were used to characterize the sample. Chi-square and Kruskal-Wallis tests assessed associations between demographics, KAP, and perceived risk. Kruskal-Wallis test compared KAP across patients with MS, health care professionals, and laypeople. Logistic regression assessed the perceived risk as a dependent dichotomized variable (low and moderate-to-high risk) and immunocompromised status or vaccination hesitancy as independent variables when controlling for age, sex, and education. Statistical significance was set at <italic>P</italic>&#x003C;.05.</p><p>A qualitative thematic analysis was performed and coded on participants&#x2019; comments by 2 researchers (AB-Z and JS) to identify key themes reaching data saturation. Participants&#x2019; open-ended comments were analyzed using thematic analysis following the framework described by Braun and Clarke [<xref ref-type="bibr" rid="ref42">42</xref>-<xref ref-type="bibr" rid="ref45">45</xref>], with consideration of their updated recommendations for good practice in thematic analysis. The analysis followed the 6-phase approach, including familiarization with the data, generation of initial codes, identification of candidate themes, review and refinement of themes, definition and naming of themes, and final reporting. Two researchers independently reviewed and coded participants&#x2019; written responses to ensure analytic rigor. An inductive approach was used, allowing themes to emerge directly from the data rather than applying predetermined categories. Coding discrepancies were discussed and resolved through consensus to refine the coding framework and ensure consistent interpretation of the data. To enhance the trustworthiness of the qualitative analysis, several strategies were applied. Credibility was supported through independent coding and collaborative discussions between researchers during the analytic process. Dependability was strengthened through systematic documentation of coding decisions and theme development. Confirmability was addressed by grounding interpretations in participants&#x2019; responses and maintaining transparency in the analytic procedures. Transferability was supported by providing contextual information about the study population and setting to allow readers to assess the potential applicability of the findings to other contexts. Data saturation was considered achieved when no additional themes or meaningful insights emerged from the participants&#x2019; responses. Reflexivity was also considered throughout the analysis, with the researchers acknowledging their professional backgrounds and engaging in regular discussions to minimize potential bias and ensure that interpretations remained closely aligned with participants&#x2019; perspectives [<xref ref-type="bibr" rid="ref42">42</xref>-<xref ref-type="bibr" rid="ref45">45</xref>].</p></sec></sec><sec id="s3" sec-type="results"><title>Results</title><sec id="s3-1"><title>Quantitative Analysis</title><p>The study included 148 participants, 43 (29%) patients with MS, 50 (33.8%) health care professionals (90% nurses and 10% physicians), and 55 (37.2%) laypeople (<xref ref-type="table" rid="table1">Tables 1</xref> and <xref ref-type="table" rid="table2">2</xref>). The majority of the participants were female and had college education. The characteristics of the sample and demographics characteristics of the participants are given in <xref ref-type="table" rid="table1">Tables 1</xref> and <xref ref-type="table" rid="table2">2</xref>, respectively. Participant responses revealed a high level of awareness and knowledge regarding the COVID-19 pandemic, including its etiology, transmission, and clinical manifestations (<xref ref-type="table" rid="table3">Table 3</xref>). For example, 116 (91.3%) participants correctly identified the viral pathogen responsible for COVID-19 and 121 (94.5%) knew its transmission (Questions 18 and 19; <xref ref-type="table" rid="table3">Table 3</xref>). Despite their high basic knowledge, 53.4% (n=79) of respondents indicated a need for further education concerning medical care and available treatment options for COVID-19, underscoring persistent knowledge gaps that can influence decision-making and health care&#x2014;seeking behaviors (<xref ref-type="table" rid="table1">Tables 1</xref><xref ref-type="table" rid="table2"/>-<xref ref-type="table" rid="table3">3</xref>).</p><table-wrap id="t1" position="float"><label>Table 1.</label><caption><p>Characteristics of the sample (N=148).</p></caption><table id="table1" frame="hsides" rules="groups"><thead><tr><td align="left" valign="bottom">Characteristic</td><td align="left" valign="bottom">Value</td></tr></thead><tbody><tr><td align="left" valign="top">Participants, n (%)</td><td align="left" valign="top">&#x2003;</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Laypeople</td><td align="left" valign="top">55 (37.2)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Health care professionals</td><td align="left" valign="top">50 (33.8)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Patients with MS<sup><xref ref-type="table-fn" rid="table1fn1">a</xref></sup></td><td align="left" valign="top">43 (29)</td></tr><tr><td align="left" valign="top">Age (y) (continuous), mean (SD)</td><td align="left" valign="top">49.5 (15.3)</td></tr><tr><td align="left" valign="top">Age group (y), n (%)</td><td align="left" valign="top">&#x2003;</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>18&#x2010;30</td><td align="left" valign="top">18 (12.3)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>31&#x2010;45</td><td align="left" valign="top">36 (24.7)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>46&#x2010;60</td><td align="left" valign="top">56 (37.3)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>&#x003E;60</td><td align="left" valign="top">36 (24.7)</td></tr><tr><td align="left" valign="top">Sex</td><td align="left" valign="top">&#x2003;</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Female</td><td align="left" valign="top">118 (79.7)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Male</td><td align="left" valign="top">27 (18.2)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Other</td><td align="left" valign="top">2 (1.4)</td></tr><tr><td align="left" valign="top">Level of education, n (%)</td><td align="left" valign="top">&#x2003;</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>High school degree</td><td align="left" valign="top">9 (6.5)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Bachelor&#x2019;s degree</td><td align="left" valign="top">55 (37.2)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Master&#x2019;s degree</td><td align="left" valign="top">55 (37.2)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Doctoral degree</td><td align="left" valign="top">13 (8.8)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Other</td><td align="left" valign="top">15 (10.1)</td></tr><tr><td align="left" valign="top">Religion, n (%)</td><td align="left" valign="top">&#x2003;</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Catholic</td><td align="left" valign="top">54 (36.5)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Jewish</td><td align="left" valign="top">39 (26.5)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Buddhist</td><td align="left" valign="top">4 (2.8)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Nonreligious</td><td align="left" valign="top">38 (25.5)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Other</td><td align="left" valign="top">12 (8.4)</td></tr><tr><td align="left" valign="top">Heard about COVID-19 infection, n (%)</td><td align="left" valign="top">&#x2003;</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Yes</td><td align="left" valign="top">137 (92.6)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>No</td><td align="left" valign="top">10 (6.8)</td></tr><tr><td align="left" valign="top">Tested positive for COVID-19, n (%)</td><td align="left" valign="top">&#x2003;</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Yes</td><td align="left" valign="top">8 (5.4)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>No</td><td align="left" valign="top">140 (94.6)</td></tr><tr><td align="left" valign="top">Are you immunocompromised, n (%)</td><td align="left" valign="top">&#x2003;</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Yes</td><td align="left" valign="top">33 (22.3)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>No</td><td align="left" valign="top">69 (46.6)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Not applicable</td><td align="left" valign="top">29 (19.6)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>I don&#x2019;t know</td><td align="left" valign="top">9 (6.1)</td></tr><tr><td align="left" valign="top">COVID-19 information sources, n (%)</td><td align="left" valign="top">&#x2003;</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Relatives and friends</td><td align="left" valign="top">82 (55.4)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Radio</td><td align="left" valign="top">75 (50.7)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Television</td><td align="left" valign="top">126 (85.1)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Health care professionals</td><td align="left" valign="top">133 (89.9)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Social media</td><td align="left" valign="top">39 (26.4)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Governmental officials</td><td align="left" valign="top">56 (37.8)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Newspapers and flyers</td><td align="left" valign="top">93 (62.8)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Internet and browsers</td><td align="left" valign="top">126 (85.1)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Mobile phone and texts</td><td align="left" valign="top">40 (27)</td></tr><tr><td align="left" valign="top">Areas where more COVID-19 information is needed, n (%)</td><td align="left" valign="top">&#x2003;</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Cause and origin of the disease</td><td align="left" valign="top">30 (20.3)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Signs and symptoms of the disease</td><td align="left" valign="top">30 (20.3)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Ways to prevent the disease</td><td align="left" valign="top">49 (33.1)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Medical care and treatment options</td><td align="left" valign="top">79 (53.4)</td></tr></tbody></table><table-wrap-foot><fn id="table1fn1"><p><sup>a</sup>MS: multiple sclerosis.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t2" position="float"><label>Table 2.</label><caption><p>Demographic characteristics of participants by group (N=148).<sup><xref ref-type="table-fn" rid="table2fn1">a</xref></sup></p></caption><table id="table2" frame="hsides" rules="groups"><thead><tr><td align="left" valign="bottom">Characteristic</td><td align="left" valign="bottom">Patients with MS<sup><xref ref-type="table-fn" rid="table2fn2">b</xref></sup> (n=43)</td><td align="left" valign="bottom">Laypeople (n=55)</td><td align="left" valign="bottom">Health care professionals (n=50)</td><td align="left" valign="bottom">Missing data</td></tr></thead><tbody><tr><td align="left" valign="top">Age (y), mean (SD)</td><td align="left" valign="top">54.10 (12.37)</td><td align="left" valign="top">52.15 (17.25)</td><td align="left" valign="top">43.76 (13.36)</td><td align="left" valign="top">1</td></tr><tr><td align="left" valign="top">Age group (y), n (%)</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">5</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>18&#x2010;30</td><td align="left" valign="top">1 (2.5)</td><td align="left" valign="top">6 (11.5)</td><td align="left" valign="top">9 (17.6)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>31&#x2010;45</td><td align="left" valign="top">5 (12.5)</td><td align="left" valign="top">12 (23.1)</td><td align="left" valign="top">19 (37.3)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>46&#x2010;60</td><td align="left" valign="top">24 (60)</td><td align="left" valign="top">16 (30.8)</td><td align="left" valign="top">16 (31.4)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>&#x003E;60</td><td align="left" valign="top">10 (25)</td><td align="left" valign="top">18 (34.6)</td><td align="left" valign="top">7 (13.7)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Sex, n (%)</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">4</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Female</td><td align="left" valign="top">33 (80.5)</td><td align="left" valign="top">38 (71.7)</td><td align="left" valign="top">45 (90)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Male</td><td align="left" valign="top">8 (19.5)</td><td align="left" valign="top">14 (26.4)</td><td align="left" valign="top">4 (8)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Other</td><td align="left" valign="top">0 (0)</td><td align="left" valign="top">1 (1.9)</td><td align="left" valign="top">1 (2)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Education level, n (%)</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">3</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>High school diploma</td><td align="left" valign="top">7 (17.1)</td><td align="left" valign="top">1 (1.9)</td><td align="left" valign="top">0 (0)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Bachelor&#x2019;s degree</td><td align="left" valign="top">15 (36.6)</td><td align="left" valign="top">23 (43.4)</td><td align="left" valign="top">17 (33.3)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Master&#x2019;s degree</td><td align="left" valign="top">9 (22)</td><td align="left" valign="top">20 (37.7)</td><td align="left" valign="top">26 (51)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Doctoral degree</td><td align="left" valign="top">3 (7.3)</td><td align="left" valign="top">2 (3.8)</td><td align="left" valign="top">7 (13.7)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Other</td><td align="left" valign="top">7 (17.1)</td><td align="left" valign="top">7 (13)</td><td align="left" valign="top">1 (2)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Religion, n (%)</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">3</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Catholic</td><td align="left" valign="top">18 (43.9)</td><td align="left" valign="top">17 (32.1)</td><td align="left" valign="top">19 (37.2)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Jewish</td><td align="left" valign="top">10 (24.4)</td><td align="left" valign="top">21 (39.6)</td><td align="left" valign="top">6 (11.8)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Buddhist</td><td align="left" valign="top">1 (2.4)</td><td align="left" valign="top">1 (1.9)</td><td align="left" valign="top">2 (3.9)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Nonreligious</td><td align="left" valign="top">9 (22)</td><td align="left" valign="top">10 (18.8)</td><td align="left" valign="top">19 (37.3)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Other</td><td align="left" valign="top">3 (7.3)</td><td align="left" valign="top">4 (7.6)</td><td align="left" valign="top">5 (9.8)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Heard of COVID-19, n (%)</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">3</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Yes</td><td align="left" valign="top">39 (95.1)</td><td align="left" valign="top">49 (92.5)</td><td align="left" valign="top">47 (92.2)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>No</td><td align="left" valign="top">2 (4.9)</td><td align="left" valign="top">4 (7.5)</td><td align="left" valign="top">4 (7.8)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Tested positive for COVID-19, n (%)</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">2</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Yes</td><td align="left" valign="top">1 (2.3)</td><td align="left" valign="top">3 (5.5)</td><td align="left" valign="top">4 (8)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>No</td><td align="left" valign="top">40 (93)</td><td align="left" valign="top">52 (94.5)</td><td align="left" valign="top">46 (92)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Immunocompromised status, n (%)</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">8</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Yes</td><td align="left" valign="top">26 (63.4)</td><td align="left" valign="top">3 (6.1)</td><td align="left" valign="top">4 (8)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>No</td><td align="left" valign="top">7 (17.1)</td><td align="left" valign="top">33 (67.3)</td><td align="left" valign="top">29 (58)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Not applicable</td><td align="left" valign="top">1 (2.4)</td><td align="left" valign="top">12 (24.5)</td><td align="left" valign="top">16 (32)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>I don&#x2019;t know</td><td align="left" valign="top">7 (17.1)</td><td align="left" valign="top">1 (2)</td><td align="left" valign="top">1 (2)</td><td align="left" valign="top"/></tr></tbody></table><table-wrap-foot><fn id="table2fn1"><p><sup>a</sup>Percentages may not total 100 due to rounding.</p></fn><fn id="table2fn2"><p><sup>b</sup>MS: multiple sclerosis.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t3" position="float"><label>Table 3.</label><caption><p>Knowledge, attitudes, and practices differences among the 3 groups of participants.</p></caption><table id="table3" frame="hsides" rules="groups"><thead><tr><td align="left" valign="bottom">Knowledge, attitudes, and practices<sup><xref ref-type="table-fn" rid="table3fn1">a</xref></sup></td><td align="left" valign="bottom">Full sample, n (%)</td><td align="left" valign="bottom">Laypeople, n (%)</td><td align="left" valign="bottom">Patients with MS<sup><xref ref-type="table-fn" rid="table3fn2">b</xref></sup>, n (%)</td><td align="left" valign="bottom">Health care professionals, n (%)</td><td align="left" valign="bottom">Effect size Cramer <italic>V</italic></td></tr></thead><tbody><tr><td align="left" valign="top">Knowledge</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>12. COVID-19 exists globally and locally</td><td align="left" valign="top">147 (99.3)</td><td align="left" valign="top">53 (36.6)</td><td align="left" valign="top">41 (28.3)</td><td align="left" valign="top">51 (35.2)</td><td align="left" valign="top">Constant</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>13. Possible to recover and survive</td><td align="left" valign="top">126 (99.2)</td><td align="left" valign="top">46 (36.5)</td><td align="left" valign="top">38 (29.2)</td><td align="left" valign="top">43 (34.1)</td><td align="left" valign="top">0.136</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>14. Possible to have COVID-19 without issues</td><td align="left" valign="top">128 (100)</td><td align="left" valign="top">46 (35.7)</td><td align="left" valign="top">38 (29.7)</td><td align="left" valign="top">44 (34.4)</td><td align="left" valign="top">Constant</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>18. The cause for the COVID-19&#x2014;virus</td><td align="left" valign="top">116 (91.3)</td><td align="left" valign="top">40 (34.5)</td><td align="left" valign="top">35 (30.2)</td><td align="left" valign="top">41 (35.3)</td><td align="left" valign="top">0.117</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>19. How does a person get COVID-19&#x2014;droplets of coughing and sneezing</td><td align="left" valign="top">121 (94.5)</td><td align="left" valign="top">43 (35.5)</td><td align="left" valign="top">36 (29.8)</td><td align="left" valign="top">42 (34.7)</td><td align="left" valign="top">0.072</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>20. What is the worse sign and symptom of COVID&#x2014;breathing difficulty</td><td align="left" valign="top">125 (97.7)</td><td align="left" valign="top">46 (36.8)</td><td align="left" valign="top">36 (28.8)</td><td align="left" valign="top">43 (34.4)</td><td align="left" valign="top">0.162</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>21. Preventing COVID-19 with blood and body precautions</td><td align="left" valign="top">44 (29.7)</td><td align="left" valign="top">28 (35)</td><td align="left" valign="top">12 (31.6)</td><td align="left" valign="top">28 (35)</td><td align="left" valign="top">0.048</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>22. Preventing COVID-19 by avoiding crowds</td><td align="left" valign="top">104 (81.3)</td><td align="left" valign="top">36 (34.7)</td><td align="left" valign="top">35 (33.7)</td><td align="left" valign="top">33 (31.7)</td><td align="left" valign="top">0.180</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>23. Protection by not touching other</td><td align="left" valign="top">117 (89.9)</td><td align="left" valign="top">43 (36.8)</td><td align="left" valign="top">35 (29.9)</td><td align="left" valign="top">39 (33.3)</td><td align="left" valign="top">0.097</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>24. COVID-19 can be better treated in a facility</td><td align="left" valign="top">67 (45.3)</td><td align="left" valign="top">19 (28.4)</td><td align="left" valign="top">22 (32.8)</td><td align="left" valign="top">26 (38.8)</td><td align="left" valign="top">0.169</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>25. Better to go to a facility since family is protected</td><td align="left" valign="top">59 (39.9)</td><td align="left" valign="top">20 (33.9)</td><td align="left" valign="top">17 (28.8)</td><td align="left" valign="top">22 (37.3)</td><td align="left" valign="top">0.127</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>26. COVID-19 prevention by bathing with hot water</td><td align="left" valign="top">121 (83.1)</td><td align="left" valign="top">43 (35.5)</td><td align="left" valign="top">32 (26.4)</td><td align="left" valign="top">46 (38)</td><td align="left" valign="top">0.177</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>27. COVID-19 is transmitted via air</td><td align="left" valign="top">116 (79.7)</td><td align="left" valign="top">44 (37.9)</td><td align="left" valign="top">31 (26.7)</td><td align="left" valign="top">41 (35.3)</td><td align="left" valign="top">0.106</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>28. COVID-19 can be transmitted by mosquito bites</td><td align="left" valign="top">93 (72.7)</td><td align="left" valign="top">31 (33.3)</td><td align="left" valign="top">27 (29)</td><td align="left" valign="top">35 (37.6)</td><td align="left" valign="top">0.196</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>29. Complementary medicine can treat COVID-19</td><td align="left" valign="top">76 (52.7)</td><td align="left" valign="top">22 (28.9)</td><td align="left" valign="top">23 (30.3)</td><td align="left" valign="top">31 (40.8)</td><td align="left" valign="top">0.198<sup><xref ref-type="table-fn" rid="table3fn3">c</xref></sup></td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>30. Spirituality and religion can treat COVID</td><td align="left" valign="top">113 (88.3)</td><td align="left" valign="top">39 (34.5)</td><td align="left" valign="top">34 (30.1)</td><td align="left" valign="top">40 (35.4)</td><td align="left" valign="top">0.081</td></tr><tr><td align="left" valign="top">Attitudes</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>31. What happens if COVID suspected&#x2014;to the hospital</td><td align="left" valign="top">126 (85.1)</td><td align="left" valign="top">39 (30.1)</td><td align="left" valign="top">43 (34.9)</td><td align="left" valign="top">44 (34.9)</td><td align="left" valign="top">0.196</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>32. COVID-19 diagnosis must be admitted</td><td align="left" valign="top">105 (71.6)</td><td align="left" valign="top">38 (36.2)</td><td align="left" valign="top">27 (25.7)</td><td align="left" valign="top">40 (38.1)</td><td align="left" valign="top">0.165<sup><xref ref-type="table-fn" rid="table3fn3">c</xref></sup></td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>33. COVID-19 exposed must be quarantined</td><td align="left" valign="top">133 (91.2)</td><td align="left" valign="top">49 (36.8)</td><td align="left" valign="top">37 (27.8)</td><td align="left" valign="top">47 (35.3)</td><td align="left" valign="top">0.086</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>34. Suspicion that you had COVID-19, hospitalized</td><td align="left" valign="top">53 (35.8)</td><td align="left" valign="top">18 (34)</td><td align="left" valign="top">13 (24.5)</td><td align="left" valign="top">22 (41.5)</td><td align="left" valign="top">0.273<sup><xref ref-type="table-fn" rid="table3fn4">d</xref></sup></td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>35. Fever, would you go to a facility</td><td align="left" valign="top">73 (50)</td><td align="left" valign="top">23 (31.5)</td><td align="left" valign="top">21 (28.8)</td><td align="left" valign="top">29 (39.7)</td><td align="left" valign="top">0.093</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>36. Family suspected, hospital or avoid contact</td><td align="left" valign="top">117 (91.4)</td><td align="left" valign="top">43 (36.8)</td><td align="left" valign="top">35 (29.9)</td><td align="left" valign="top">39 (33.3)</td><td align="left" valign="top">0.078</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>37. Complementary medicine cure COVID</td><td align="left" valign="top">66 (51.6)</td><td align="left" valign="top">21 (31.8)</td><td align="left" valign="top">22 (33.3)</td><td align="left" valign="top">23 (34.8)</td><td align="left" valign="top">0.187</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>39. A student recovered COVID-19, put others at risk</td><td align="left" valign="top">70 (48.6)</td><td align="left" valign="top">19 (27.1)</td><td align="left" valign="top">16 (22.9)</td><td align="left" valign="top">35 (50)</td><td align="left" valign="top">0.248<sup><xref ref-type="table-fn" rid="table3fn4">d</xref></sup></td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>40. A person recovered COVID-19, back in community</td><td align="left" valign="top">136 (93.2)</td><td align="left" valign="top">49 (36)</td><td align="left" valign="top">37 (27.2)</td><td align="left" valign="top">50 (36.8)</td><td align="left" valign="top">0.170<sup><xref ref-type="table-fn" rid="table3fn3">c</xref></sup></td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>41. Shop owner, recovered, shop there buying produce</td><td align="left" valign="top">88 (60.8)</td><td align="left" valign="top">32 (36.4)</td><td align="left" valign="top">22 (25)</td><td align="left" valign="top">34 (38.6)</td><td align="left" valign="top">0.116</td></tr><tr><td align="left" valign="top">Practices</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>37. Actions to prevent COVID-19</td><td align="left" valign="top">144 (97.9)</td><td align="left" valign="top">53 (36.8)</td><td align="left" valign="top">40 (27.8)</td><td align="left" valign="top">51 (35.4)</td><td align="left" valign="top">0.133</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>38. Behavior to avoid infection and avoid public places</td><td align="left" valign="top">144 (97.3)</td><td align="left" valign="top">45 (36.3)</td><td align="left" valign="top">36 (29)</td><td align="left" valign="top">43 (34.7)</td><td align="left" valign="top">0.080</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>42. COVID-19 vaccine&#x2014;accept</td><td align="left" valign="top">115 (89.8)</td><td align="left" valign="top">41 (35.7)</td><td align="left" valign="top">36 (31.3)</td><td align="left" valign="top">38 (33)</td><td align="left" valign="top">0.112</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>43. COVID-19 vaccine&#x2014;accept for your children</td><td align="left" valign="top">83 (93.7)</td><td align="left" valign="top">31 (37.3)</td><td align="left" valign="top">24 (28.9)</td><td align="left" valign="top">28 (33.7)</td><td align="left" valign="top">0.047</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>44. COVID treatment only with animal research&#x2014;accept</td><td align="left" valign="top">32 (25)</td><td align="left" valign="top">11 (34.4)</td><td align="left" valign="top">13 (40.6)</td><td align="left" valign="top">8 (25)</td><td align="left" valign="top">0.121</td></tr></tbody></table><table-wrap-foot><fn id="table3fn1"><p><sup>a</sup>KAP questions adapted from CDC/Ebola survey.</p></fn><fn id="table3fn2"><p><sup>b</sup>MS: multiple sclerosis.</p></fn><fn id="table3fn3"><p><sup>c</sup>.05&#x003C;<italic>P</italic>&#x003C;.10.</p></fn><fn id="table3fn4"><p><sup>d</sup><italic>P</italic>&#x003C;.05.</p></fn></table-wrap-foot></table-wrap><p>A detailed analysis of participant responses revealed considerable variability in attitudes and behaviors related to COVID-19 infection and recovery. Specifically, a substantial proportion of respondents indicated engagement in preventative measures and a willingness to reintegrate individuals into their communities following recovery from COVID-19, demonstrating a generally accepting attitude toward postinfection social reintegration (Questions 37, 39, 40, and 41; <xref ref-type="table" rid="table3">Tables 3</xref> and <xref ref-type="table" rid="table4">4</xref>). Additionally, COVID vaccination hesitancy did not predict the perceived risk of contracting the virus among the participants when controlling for age, sex, and education (<italic>B</italic>=&#x2212;0.450, <italic>W</italic>[1]=0.505, <italic>P</italic>=.48). However, vaccination acceptance rates were notably high, as 115 (89.8%) participants expressed their willingness to receive an approved COVID-19 vaccine (Question 42; <xref ref-type="table" rid="table3">Tables 3</xref> and <xref ref-type="table" rid="table4">4</xref>). Among the 95 (70%) participants identified as having children, 83 (87%) stated their intent to vaccinate their children, indicating a strong overall endorsement of vaccination as a preventive strategy (Question 43; <xref ref-type="table" rid="table3">Tables 3</xref> and <xref ref-type="table" rid="table4">4</xref>). Older participants were more likely to accept an approved COVID vaccine (<italic>&#x03C7;</italic><sup>2</sup><sub>2</sub>=5.43, <italic>P</italic>=.07).</p><table-wrap id="t4" position="float"><label>Table 4.</label><caption><p>Association between knowledge, attitudes, and practices and perceived risk.</p></caption><table id="table4" frame="hsides" rules="groups"><thead><tr><td align="left" valign="bottom">Knowledge, attitudes, and practices correct responses<sup><xref ref-type="table-fn" rid="table4fn1">a</xref></sup></td><td align="left" valign="bottom"><italic>&#x03C7;</italic><sup>2</sup> (<italic>df</italic>)</td><td align="left" valign="bottom"><italic>P</italic> value</td><td align="left" valign="bottom">Effect size Cramer V</td></tr></thead><tbody><tr><td align="left" valign="top">Knowledge</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">&#x2003;12. COVID-19 exists globally and locally</td><td align="left" valign="top">Constant (Yes)</td><td align="left" valign="top">&#x2014;<sup><xref ref-type="table-fn" rid="table4fn2">b</xref></sup></td><td align="left" valign="top">&#x2014;</td></tr><tr><td align="left" valign="top">&#x2003;13. Possible to recover and survive</td><td align="left" valign="top">0.250 (1)</td><td align="left" valign="top">.62</td><td align="left" valign="top">0.043</td></tr><tr><td align="left" valign="top">&#x2003;14. Possible to have COVID-19 without signs and symptoms</td><td align="left" valign="top">Constant</td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">&#x2014;</td></tr><tr><td align="left" valign="top">&#x2003;21. Preventing COVID-19 with blood and body precautions (No)</td><td align="left" valign="top">3.107 (1)</td><td align="left" valign="top">.09<sup><xref ref-type="table-fn" rid="table4fn3">c</xref></sup></td><td align="left" valign="top">0.151</td></tr><tr><td align="left" valign="top">&#x2003;22. Preventing COVID-19 by avoiding crowds</td><td align="left" valign="top">7.469 (2)</td><td align="left" valign="top">.02<sup><xref ref-type="table-fn" rid="table4fn4">d</xref></sup></td><td align="left" valign="top">0.234</td></tr><tr><td align="left" valign="top">&#x2003;23. Protection by not touching others</td><td align="left" valign="top">1.813 (2)</td><td align="left" valign="top">.40</td><td align="left" valign="top">0.115</td></tr><tr><td align="left" valign="top">&#x2003;24. COVID-19 can be better treated in a facility (No)</td><td align="left" valign="top">9.800 (2)</td><td align="left" valign="top">.02<sup><xref ref-type="table-fn" rid="table4fn4">d</xref></sup></td><td align="left" valign="top">0.267</td></tr><tr><td align="left" valign="top">&#x2003;25. Better to go to a facility since family is protected (No)</td><td align="left" valign="top">5.708 (2)</td><td align="left" valign="top">.13</td><td align="left" valign="top">0.204</td></tr><tr><td align="left" valign="top">&#x2003;26. COVID-19 prevention by bathing with hot water (No)</td><td align="left" valign="top">3.757 (2)</td><td align="left" valign="top">.15</td><td align="left" valign="top">0.166</td></tr><tr><td align="left" valign="top">&#x2003;27. COVID-19 is transmitted through air</td><td align="left" valign="top">2.357 (2)</td><td align="left" valign="top">.31</td><td align="left" valign="top">0.131</td></tr><tr><td align="left" valign="top">&#x2003;28. COVID-19 can be transmitted by mosquito bites (No)</td><td align="left" valign="top">0.002 (1)</td><td align="left" valign="top">.96</td><td align="left" valign="top">0.004</td></tr><tr><td align="left" valign="top">&#x2003;29. Complementary medicine can treat COVID-19 (No)</td><td align="left" valign="top">5.320 (2)</td><td align="left" valign="top">.15</td><td align="left" valign="top">0.197</td></tr><tr><td align="left" valign="top">&#x2003;30. Spirituality or religion can treat COVID-19 (No)</td><td align="left" valign="top">4.932 (2)</td><td align="left" valign="top">.18</td><td align="left" valign="top">0.190</td></tr><tr><td align="left" valign="top">Attitudes</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">&#x2003;32. COVID-19 diagnosis must be admitted (No)</td><td align="left" valign="top">1.635 (2)</td><td align="left" valign="top">.65</td><td align="left" valign="top">0.109</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>33. COVID-19 exposed must be quarantined</td><td align="left" valign="top">0.832 (2)</td><td align="left" valign="top">.66</td><td align="left" valign="top">0.078</td></tr><tr><td align="left" valign="top">&#x2003;34. Suspicion that you had COVID-19, then would you get admitted (No)</td><td align="left" valign="top">7.595 (2)</td><td align="left" valign="top">.05<sup><xref ref-type="table-fn" rid="table4fn3">c</xref></sup></td><td align="left" valign="top">0.235</td></tr><tr><td align="left" valign="top">&#x2003;35. Fever, would you go to a facility</td><td align="left" valign="top">4.674 (2)</td><td align="left" valign="top">.10<sup><xref ref-type="table-fn" rid="table4fn3">c</xref></sup></td><td align="left" valign="top">0.185</td></tr><tr><td align="left" valign="top">&#x2003;39. A student recovered from COVID-19 put others at risk at school (No)</td><td align="left" valign="top">1.199 (2)</td><td align="left" valign="top">.88</td><td align="left" valign="top">0.094</td></tr><tr><td align="left" valign="top">&#x2003;40. Shop owner recovered from COVID-19, you will shop there buying produce</td><td align="left" valign="top">0.396 (2)</td><td align="left" valign="top">.94</td><td align="left" valign="top">0.054</td></tr><tr><td align="left" valign="top">&#x2003;41. A person that recovered COVID-19, back in community</td><td align="left" valign="top">1.540 (2)</td><td align="left" valign="top">.46</td><td align="left" valign="top">0.106</td></tr><tr><td align="left" valign="top">Practices</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">&#x2003;37. Actions to prevent COVID-19</td><td align="left" valign="top">Constant (Yes)</td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">&#x2014;</td></tr><tr><td align="left" valign="top">&#x2003;42. COVID-19 vaccine&#x2014;accept</td><td align="left" valign="top">1.313 (2)</td><td align="left" valign="top">.52</td><td align="left" valign="top">0.098</td></tr><tr><td align="left" valign="top">&#x2003;43. COVID-19 vaccine&#x2014;accept for your children (n=95 children had, 70%)</td><td align="left" valign="top">7.245 (2)</td><td align="left" valign="top">.06<sup><xref ref-type="table-fn" rid="table4fn3">c</xref></sup></td><td align="left" valign="top">0.230</td></tr><tr><td align="left" valign="top">&#x2003;44. COVID-19 treatment only with animal research&#x2014;accept it</td><td align="left" valign="top">4.713 (2)</td><td align="left" valign="top">.19</td><td align="left" valign="top">0.185</td></tr></tbody></table><table-wrap-foot><fn id="table4fn1"><p><sup>a</sup>KAP questions adapted from CDC/Ebola survey.</p></fn><fn id="table4fn2"><p><sup>b</sup>Not applicable.</p></fn><fn id="table4fn3"><p><sup>c</sup>.05&#x003C;<italic>P</italic>&#x003C;.10.</p></fn><fn id="table4fn4"><p><sup>d</sup><italic>P</italic>&#x003C;.05.</p></fn></table-wrap-foot></table-wrap><p>A comprehensive analysis of participant responses across the 3 study groups&#x2014;laypeople, individuals diagnosed with MS, and health care professionals&#x2014;revealed a few statistically significant differences in overall KAP and perceived risk related to COVID-19 (<xref ref-type="table" rid="table4">Table 4</xref>). There was a statistically significant difference between the 3 groups associated with their perceived risk (<italic>&#x03C7;</italic><sup>2</sup><sub>6</sub>=12.65, <italic>P</italic>=.049) (<xref ref-type="table" rid="table5">Table 5</xref>). Thus, lay participants have reported mostly a moderate perceived risk for COVID as compared with patients with MS and health care providers who reported mainly a high risk to contract the virus (<xref ref-type="table" rid="table3">Tables 3</xref><xref ref-type="table" rid="table4"/>-<xref ref-type="table" rid="table5">5</xref>). Additionally, health care professionals were significantly more likely than the other groups to agree that people could safely return to school or work following recovery from COVID-19 without posing a risk to others (<italic>P</italic>&#x003C;.05). Further analysis highlighted considerable uncertainty among participants regarding the appropriate facilities for COVID-19 treatment and the safety of reintegration into community settings postrecovery (Questions 24, 25, 34, 35, 39; <xref ref-type="table" rid="table3">Tables 3</xref> and <xref ref-type="table" rid="table4">4</xref>). Moreover, uncertainty was prevalent in responses related to novel treatment options, particularly those studied exclusively in animal models (Question 44; <xref ref-type="table" rid="table3">Tables 3</xref> and <xref ref-type="table" rid="table4">4</xref>).</p><table-wrap id="t5" position="float"><label>Table 5.</label><caption><p>Perceived risk of coronavirus/COVID-19 among the participants.</p></caption><table id="table5" frame="hsides" rules="groups"><thead><tr><td align="left" valign="bottom">COVID-19 perceived risk</td><td align="left" valign="bottom">Laypeople, n (%)</td><td align="left" valign="bottom">Patients with multiple sclerosis, n (%)</td><td align="left" valign="bottom">Health care professionals, n (%)</td><td align="left" valign="bottom">Total, n (%)</td></tr></thead><tbody><tr><td align="left" valign="top">No risk</td><td align="left" valign="top">0 (0.0)</td><td align="left" valign="top">1 (2.4)</td><td align="left" valign="top">0 (0.0)</td><td align="left" valign="top">1 (0.7)</td></tr><tr><td align="left" valign="top">Mild risk</td><td align="left" valign="top">7 (13.2)</td><td align="left" valign="top">12 (29.3)</td><td align="left" valign="top">7 (14.0)</td><td align="left" valign="top">26 (18.1)</td></tr><tr><td align="left" valign="top">Moderate risk</td><td align="left" valign="top">36 (67.9)</td><td align="left" valign="top">16 (39.0)</td><td align="left" valign="top">29 (58.0)</td><td align="left" valign="top">81 (56.3)</td></tr><tr><td align="left" valign="top">High risk</td><td align="left" valign="top">6 (11.3)</td><td align="left" valign="top">8 (19.5)</td><td align="left" valign="top">13 (26.0)</td><td align="left" valign="top">27 (18.8)</td></tr><tr><td align="left" valign="top">Unsure</td><td align="left" valign="top">4 (7.5)</td><td align="left" valign="top">4 (9.8)</td><td align="left" valign="top">1 (2.0)</td><td align="left" valign="top">9 (6.3)</td></tr><tr><td align="left" valign="top">Total</td><td align="left" valign="top">53 (100)</td><td align="left" valign="top">41 (100)</td><td align="left" valign="top">50 (100)</td><td align="left" valign="top">144 (100)</td></tr></tbody></table></table-wrap><p>Perceived risk analysis among the participants have shown variable results. There was a trend toward a negative correlation between perceived level of risk and participant age, with older individuals demonstrating lower perceived susceptibility to COVID-19 infection (<italic>t</italic><sub>143</sub>=&#x2212;1.781, <italic>P</italic>=.06). Chi-square bivariate analysis did not show a statistically significant association between gender (female, male, nonbinary) (<italic>&#x03C7;</italic><sup>2</sup><sub>2</sub>=4.452, <italic>P</italic>=.11), religious affiliation (<italic>&#x03C7;</italic><sup>2</sup><sub>1</sub>=0.698, <italic>P</italic>=.40), and education (<italic>&#x03C7;</italic><sup>2</sup><sub>1</sub>=0.660, <italic>P</italic>=.42) and perceived risk. There was no statistically significant association between professional specialty and self-reported risk level, suggesting that risk perception was consistent across various health care disciplines. Immunocompromised status did not predict perceived risk levels when controlling for age, sex, and education (<italic>B</italic>=&#x2212;442, <italic>W</italic>[1]=.818, <italic>P</italic>=.33). Markedly, perceived risk demonstrated a statistically significant association with behavioral modifications aimed at mitigating infection risk (<xref ref-type="table" rid="table4">Table 4</xref>). Specifically, participants with moderate to high perceived susceptibility were significantly more likely to engage in risk-averse behaviors, including avoiding crowded places, a decreased likelihood of seeking care at a medical facility, or visiting a hospital if they suspected COVID-19 infection (Questions 22, 24, 34; <xref ref-type="table" rid="table3">Tables 3</xref> and <xref ref-type="table" rid="table4">4</xref>).</p></sec><sec id="s3-2"><title>Qualitative Analysis</title><p>A qualitative thematic analysis was conducted to explore participants&#x2019; perceptions of risks associated with COVID-19, following the analytic framework described by Virginia Braun and Victoria Clarke. Participants&#x2019; open-ended responses were first read repeatedly to achieve data familiarization, after which 2 researchers (AB-Z and JS) independently generated initial codes. Through an iterative and reflexive process of reviewing, comparing, and refining codes, patterns of shared meaning across the dataset were identified and organized into candidate themes. These themes were subsequently reviewed and refined to ensure internal coherence and clear distinction between themes. The analysis revealed several key themes reflecting participants&#x2019; perceptions of pandemic-related risk, including uncertainty, anxiety, fear, vulnerability, and accountability. Thematic saturation was reached when no additional patterns or themes emerged from the data. Differences and similarities in thematic expressions were examined across the 3 participant groups: individuals with MS, health care professionals, and lay community members. Across groups, dominant themes centered on feelings of uncertainty and heightened anxiety about contracting the virus, concerns about vulnerability to infection, and a perceived sense of personal and collective responsibility for infection prevention.</p><p>Participants expressed heightened concern about their perceived risk, particularly due to residing in highly affected areas, such as New York City and surrounding regions. The density of the population and the high prevalence of COVID-19 cases in these areas amplified their perceived susceptibility:</p><disp-quote><p>NYC has more cases than anywhere else in the US, and that puts everyone at risk.</p><p>I live in a densely populated city.</p><p>I think we are all at risk since thousands have contracted this virus.</p><p>I live in New Jersey, close to NY, which has a high rate of infection.</p></disp-quote><p>Another recurring theme was the perception of vulnerability due to age. Several participants highlighted concerns about their increased susceptibility to COVID-19 due to being older adults or cohabiting with elderly family members or young children. These responses illustrated an awareness of age-related risk factors:</p><disp-quote><p>I am highly concerned since I am over 60 and live near NYC.</p><p>I live with my elderly mother, and we are both at high risk.</p><p>I have young children at home, and I have to protect them from being exposed to the virus.</p></disp-quote><p>Work-related exposure also emerged as a critical factor, with participants expressing concern and vulnerability over their occupational and social interactions. Essential workers and those with frequent public interactions perceived themselves at an elevated risk due to the nature of their jobs. Representative comments included:</p><disp-quote><p>I have contact with numerous people at work and I have to continue going to work because I am an essential worker.</p><p>I am an essential worker and still mix with people from different backgrounds and locations.</p><p>Through personal interaction and work, I come into contact with people from different backgrounds who might be exposed.</p><p>As a nurse, I have experienced many events in my career, but this is beyond anything I have experienced. This pandemic makes me feel very vulnerable.</p></disp-quote><p>Patients with MS reported feeling particularly vulnerable, attributing their heightened risk to both their condition and the immunosuppressive nature of their medications. Their narratives underscored concerns about compromised immunity and the necessity for extra precautions. Statements reflecting this vulnerability included:</p><disp-quote><p>I&#x2019;m immunocompromised and at higher risk than most people. I need to be extra cautious.</p><p>I am on a medication that lowers white blood cells, and it puts me at risk for infections. I have to continue the medication following my MS team.</p><p>My immune system is compromised due to my MS. I am concerned about any imminent infection that will affect my disease.</p><p>I was very concerned about contracting the virus, therefore I decided to see my providers only via telemedicine.</p></disp-quote><p>Participants collectively acknowledged a shared responsibility in mitigating the spread of COVID-19. Some emphasized the importance of protective measures such as wearing masks and gloves, illustrating a sense of communal accountability:</p><disp-quote><p>All people need to take some sort of responsibility, like wearing a mask and gloves, because they can spread it.</p><p>Everyone needs to follow precautions set by major organizations and institutions.</p><p>As a healthcare professional, I feel responsible of teaching others about precautions and the importance of wearing masks and other measures.</p></disp-quote><p>The qualitative findings reflect a complex interplay of geographic, occupational, medical, and demographic factors shaping participants&#x2019; perceptions of risk. The overarching themes of high-risk environments, personal vulnerability, and the perceived necessity for protective behaviors provided a deeper understanding of how individuals navigated the psychological and practical challenges posed by the pandemic.</p></sec></sec><sec id="s4" sec-type="discussion"><title>Discussion</title><sec id="s4-1"><title>Principal Results</title><p>Participants in this study exhibited a high level of knowledge regarding COVID-19, including its etiology, transmission modes, and symptomatic presentation. However, knowledge gaps persisted in areas related to appropriate health care facilities, treatment options, and safe reintegration into the community following recovery. Furthermore, analysis of participant responses revealed generally positive attitudes toward COVID-19 prevention and postinfection reintegration, with high engagement in preventative behaviors and strong acceptance of vaccination for themselves (n=115, 89.8%) and their children (n=82, 87%), (n=95, 70% had children), particularly among older participants. Differences emerged across study groups, with lay participants reporting moderate perceived risk, whereas individuals with MS and health care professionals reported higher perceived risk, and health care professionals were more confident about safe reintegration into schools or workplaces. Overall, perceived risk was not significantly associated with gender, education, religious affiliation, immunocompromised status, or health care specialty, though older participants tended to perceive lower susceptibility. Importantly, higher perceived risk consistently predicted greater adoption of risk-averse behaviors, including avoidance of crowded settings and medical facilities, while notable uncertainty remained regarding appropriate treatment facilities, postrecovery community reintegration, and novel interventions, highlighting areas for targeted education and guidance.</p><p>The qualitative findings provided further context for these quantitative patterns. Thematic analysis of open-ended responses identified several dominant themes shaping participants&#x2019; perceptions of pandemic risk, including uncertainty, anxiety, fear, vulnerability, and accountability. Taken together, the integrated findings suggest that although participants possessed substantial baseline knowledge and demonstrated strong engagement in preventive behaviors, emotional responses to the pandemic, particularly uncertainty and perceived vulnerability, played a critical role in shaping risk perception and behavioral choices. Persistent uncertainty regarding treatment pathways and postrecovery reintegration further highlights the need for clear, targeted public health communication to address these specific areas of concern.</p></sec><sec id="s4-2"><title>Comparison with Prior Work</title><p>These findings align with previous national and international studies that have documented considerable public awareness of pathophysiology and transmission dynamics of COVID-19 [<xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref17">17</xref>,<xref ref-type="bibr" rid="ref23">23</xref>-<xref ref-type="bibr" rid="ref25">25</xref>,<xref ref-type="bibr" rid="ref35">35</xref>]. The sources of this knowledge likely stem from various platforms, including social media, governmental communications, and clinical medical resources. Furthermore, the World Health Organization [<xref ref-type="bibr" rid="ref46">46</xref>,<xref ref-type="bibr" rid="ref47">47</xref>] and CDC have emphasized the utility of KAP models serving as frameworks for public health education programs. Remarkably, the KAB model stresses the importance of knowledge as a foundation for behavioral shifts [<xref ref-type="bibr" rid="ref36">36</xref>], and public health authorities should use creative strategies to encourage social change and improve attitudes and behaviors [<xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref19">19</xref>,<xref ref-type="bibr" rid="ref33">33</xref>-<xref ref-type="bibr" rid="ref35">35</xref>]. Additionally, KAPs regarding COVID-19 are interconnected, but knowledge alone does not always lead to preventive behaviors [<xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref19">19</xref>,<xref ref-type="bibr" rid="ref27">27</xref>,<xref ref-type="bibr" rid="ref33">33</xref>,<xref ref-type="bibr" rid="ref34">34</xref>,<xref ref-type="bibr" rid="ref48">48</xref>]. Accordingly, our findings contribute to the growing body of literature on COVID-19 awareness and highlight the importance of targeted educational interventions to address persistent knowledge gaps.</p><p>In our study, patients with MS and health care professionals had a high perceived risk to contract the virus, while laypeople had a moderate risk (<xref ref-type="table" rid="table5">Table 5</xref>). Research shows that a higher risk perception leads to better adherence to preventive measures [<xref ref-type="bibr" rid="ref49">49</xref>]. Furthermore, patients with MS were highly concerned about becoming infected during the local peak of the COVID-19 pandemic [<xref ref-type="bibr" rid="ref50">50</xref>]. Most of our study participants have favored vaccination for themselves and their children, once a vaccine was available. Research has shown that COVID-19 vaccine hesitancy decreased during the pandemic, although 1 in 5 adults with MS were hesitant in early 2021 [<xref ref-type="bibr" rid="ref51">51</xref>]. Behaviors that deviated from originally recommended care for patients with MS were common and often self-initiated, but patients were overall compliant with continuing their disease-modifying therapies [<xref ref-type="bibr" rid="ref50">50</xref>,<xref ref-type="bibr" rid="ref51">51</xref>].</p><p>Qualitatively, our study has identified the themes of uncertainty, anxiety, fear, vulnerability, and accountability associated with the perceived risk of patients with MS, health care professionals, and laypeople. Thus, our study revealed several psychological themes that are prevalent in individuals&#x2019; perceptions of COVID-19 risk. These themes indicate the multifaceted emotional responses that individuals experience when confronted with the possibility of infection [<xref ref-type="bibr" rid="ref50">50</xref>]. Uncertainty reflects the unpredictable nature of the virus as well as MS, while anxiety and fear stem from concerns about personal and family health, and the potential for severe outcomes. Contrastingly, vulnerability highlights a sense of exposure and the limited control over preventing infection in a global pandemic. Jointly, these themes [<xref ref-type="bibr" rid="ref50">50</xref>] underscore the need for support services that address these psychological burdens, particularly in public health responses aimed at easing COVID-19&#x2013;related fears and anxiety. Similarly, Cadwgan and her colleagues [<xref ref-type="bibr" rid="ref52">52</xref>] identified a few themes to include &#x201C;uncertainty and anxiety,&#x201D; &#x201C;exacerbation of inequalities,&#x201D; and &#x201C;care provision: reaction, adaptation, and innovation&#x201D;. Mejdahl and colleagues [<xref ref-type="bibr" rid="ref53">53</xref>] noted themes of vulnerability and uncertainty related to the infection risk and social distancing. Comparably to our study, other studies highlighted the uncertainty and anxiety feelings with the risk of acute illness and worsening of the participants&#x2019; chronic illnesses [<xref ref-type="bibr" rid="ref52">52</xref>]. Our study participants, particularly the patients with MS, were concerned about their immunosuppressive status and the potential impact of COVID-19 on their MS status [<xref ref-type="bibr" rid="ref50">50</xref>]. Other studies identified themes such as fear, stigma, and social isolation [<xref ref-type="bibr" rid="ref50">50</xref>,<xref ref-type="bibr" rid="ref53">53</xref>,<xref ref-type="bibr" rid="ref54">54</xref>].</p><p>The COVID-19 pandemic has had a profound and far-reaching impact on global public health systems, revealing both strengths and vulnerabilities in health infrastructure and communication. Beyond the immediate morbidity and mortality associated with SARS-CoV-2 infection, the pandemic disrupted routine health care services, exacerbated health disparities, and strained workforce capacity [<xref ref-type="bibr" rid="ref55">55</xref>]. Public health agencies faced unprecedented challenges in disease surveillance, contact tracing, testing, and vaccine distribution, while also contending with widespread misinformation and public skepticism. This study has underscored the vast knowledge that the participants had during the early period of the pandemic, leading to partially following precautionary measures. In addition, this study underlined the critical need for sustained investment in public health preparedness, and the development of resilient health systems capable of responding to the needs of vulnerable populations, such as patients with MS and other chronic illnesses.</p></sec><sec id="s4-3"><title>Limitations</title><p>This study has several limitations that should be considered when interpreting the findings. The cross-sectional design, which captures a single point in time, does not allow for causal conclusions. A cross-sectional design was selected to efficiently assess and compare KAP related to COVID-19 among patients with MS, health care providers, and the general public during the pandemic period. The convenience sampling used limits representativeness and may introduce researcher and selection biases. Convenience sampling was employed due to logistic constraints and restricted access to participants during the pandemic, as well as the limited and specialized clinical population of individuals with MS, which made probability-based sampling difficult to implement within the study time frame. Additionally, the sample size within each group was relatively modest (n=~50), which may limit the generalizability of the results to broader populations. In particular, individuals with MS represent a specialized clinical population, and recruitment was limited to a defined sampling frame during the COVID-19 pandemic, when institutional restrictions and increased clinical demands have affected participant availability. Nevertheless, equal group sizes were intentionally used to facilitate balanced comparisons among patients, health care providers, and lay participants, thereby improving the internal validity of between-group analyses. While the quantitative methods provided valuable data on trends and patterns during the pandemic, integrating qualitative methods enriched the understanding by providing context and depth to the results including thematic saturation. Additionally, the study was conducted in New York, Connecticut, and Massachusetts, primarily with highly educated participants, so that the findings may not apply to the broader population. Lastly, demographic data on race and ethnicity and economic measures were not collected, limiting insight into underserved populations.</p></sec><sec id="s4-4"><title>Conclusions</title><p>The findings of this study underscore the critical role of KAP in shaping behaviors that reduce the spread of COVID-19 and other infectious diseases. While participants generally demonstrated good understanding and positive attitudes, variability in adherence to preventive measures highlights the need for tailored interventions. Perceived risk influenced protective behaviors, suggesting that public health messaging must address both awareness and personal relevance to effectively motivate compliance. Vulnerable populations, such as patients with MS, may benefit from targeted education and support, while health care professionals can leverage their trusted position to guide safe practices within communities. Understanding the KAP across different groups allows public health authorities to design nuanced strategies that enhance preparedness, encourage sustained behavior change, and strengthen resilience against future pandemics.</p></sec></sec></body><back><ack><p>The authors would like to express their sincere gratitude to Dr Shiela Strauss and Mr Steve Gutierrez for their valuable assistance in editing and refining this manuscript. Their thoughtful feedback and careful review greatly improved the clarity and quality of the work. The authors also extend their heartfelt appreciation to all the patients, health care providers, and laypeople who generously participated in this study. Their time, insights, and contributions were essential to the completion of this research and are deeply appreciated. The authors did not use artificial intelligence throughout this manuscript.</p></ack><notes><sec><title>Funding</title><p>The authors declared no financial support was received for this work.</p></sec><sec><title>Data Availability</title><p>The datasets generated and analyzed during this study are not publicly available due to patient confidentiality concerns, but are available from the corresponding author on reasonable request. After acceptance and publication, the datasets and accompanying manuscript describing the dataset are published with a Digital Object Identifier.</p></sec></notes><fn-group><fn fn-type="con"><p>Conceptualization: ABB-Z, MB-Z, JS</p><p>Data curation: ABB-Z, MB-Z, JS</p><p>Formal analysis: ABB-Z, JS</p><p>Investigation: ABB-Z, MB-Z, JS</p><p>Methodology: ABB-Z, MB-Z, JS</p><p>Project administration: ABB-Z, MB-Z, JS</p><p>Resources: ABB-Z, MB-Z, JS</p><p>Validation: ABB-Z, MB-Z, JS</p><p>Visualization: ABB-Z, MB-Z, JS</p><p>Writing &#x2013; original draft: ABB-Z, MB-Z, JS</p><p>Writing &#x2013; review &#x0026; editing: ABB-Z, MB-Z, JS</p><p>The author JS is currently not affiliated with any institution, but is an Independent Scholar.</p></fn><fn fn-type="conflict"><p>None declared.</p></fn></fn-group><glossary><title>Abbreviations</title><def-list><def-item><term id="abb1">CDC</term><def><p>Centers for Disease Control and Prevention</p></def></def-item><def-item><term id="abb2">GRAMMS</term><def><p>Good Reporting of a Mixed Methods Study</p></def></def-item><def-item><term id="abb3">IRB</term><def><p>institutional review board</p></def></def-item><def-item><term id="abb4">KAB</term><def><p>knowledge-attitude-behavior</p></def></def-item><def-item><term id="abb5">KAP</term><def><p>knowledge, attitudes, and practices</p></def></def-item><def-item><term id="abb6">MS</term><def><p>multiple sclerosis</p></def></def-item><def-item><term id="abb7">OR</term><def><p>odds ratio</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="ref1"><label>1</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wolf</surname><given-names>MS</given-names> </name><name name-style="western"><surname>Serper</surname><given-names>M</given-names> </name><name name-style="western"><surname>Opsasnick</surname><given-names>L</given-names> </name><etal/></person-group><article-title>Awareness, attitudes, and actions related to COVID-19 among adults with chronic conditions at the onset of the U.S. outbreak: a cross-sectional survey</article-title><source>Ann Intern Med</source><year>2020</year><month>07</month><day>21</day><volume>173</volume><issue>2</issue><fpage>100</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.7326/M20-1239</pub-id><pub-id pub-id-type="medline">32271861</pub-id></nlm-citation></ref><ref id="ref2"><label>2</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Matthews</surname><given-names>PM</given-names> </name></person-group><article-title>Chronic inflammation in multiple sclerosis - seeing what was always there</article-title><source>Nat Rev Neurol</source><year>2019</year><month>10</month><volume>15</volume><issue>10</issue><fpage>582</fpage><lpage>593</lpage><pub-id pub-id-type="doi">10.1038/s41582-019-0240-y</pub-id><pub-id pub-id-type="medline">31420598</pub-id></nlm-citation></ref><ref id="ref3"><label>3</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marcus</surname><given-names>R</given-names> </name></person-group><article-title>What is multiple sclerosis?</article-title><source>JAMA</source><year>2022</year><month>11</month><day>22</day><volume>328</volume><issue>20</issue><fpage>2078</fpage><pub-id pub-id-type="doi">10.1001/jama.2022.14236</pub-id><pub-id pub-id-type="medline">36413229</pub-id></nlm-citation></ref><ref id="ref4"><label>4</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dobson</surname><given-names>R</given-names> </name><name name-style="western"><surname>Giovannoni</surname><given-names>G</given-names> </name></person-group><article-title>Multiple sclerosis - a review</article-title><source>Eur J Neurol</source><year>2019</year><month>01</month><volume>26</volume><issue>1</issue><fpage>27</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1111/ene.13819</pub-id><pub-id pub-id-type="medline">30300457</pub-id></nlm-citation></ref><ref id="ref5"><label>5</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Klineova</surname><given-names>S</given-names> </name><name name-style="western"><surname>Lublin</surname><given-names>FD</given-names> </name></person-group><article-title>Clinical course of multiple sclerosis</article-title><source>Cold Spring Harb Perspect Med</source><year>2018</year><month>09</month><day>4</day><volume>8</volume><issue>9</issue><fpage>a028928</fpage><pub-id pub-id-type="doi">10.1101/cshperspect.a028928</pub-id><pub-id pub-id-type="medline">29358317</pub-id></nlm-citation></ref><ref id="ref6"><label>6</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ben-Zacharia</surname><given-names>AB</given-names> </name></person-group><article-title>Therapeutics for multiple sclerosis symptoms</article-title><source>Mt Sinai J Med</source><year>2011</year><volume>78</volume><issue>2</issue><fpage>176</fpage><lpage>191</lpage><pub-id pub-id-type="doi">10.1002/msj.20245</pub-id><pub-id pub-id-type="medline">21425263</pub-id></nlm-citation></ref><ref id="ref7"><label>7</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Daniels</surname><given-names>K</given-names> </name><name name-style="western"><surname>Frequin</surname><given-names>S</given-names> </name><name name-style="western"><surname>van de Garde</surname><given-names>EMW</given-names> </name><etal/></person-group><article-title>Development of an international, multidisciplinary, patient-centered standard outcome set for multiple sclerosis: the S.O.S.MS project</article-title><source>Mult Scler Relat Disord</source><year>2023</year><month>01</month><volume>69</volume><fpage>104461</fpage><pub-id pub-id-type="doi">10.1016/j.msard.2022.104461</pub-id><pub-id pub-id-type="medline">36563595</pub-id></nlm-citation></ref><ref id="ref8"><label>8</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Al Marzouqi</surname><given-names>AM</given-names> </name><name name-style="western"><surname>Otim</surname><given-names>ME</given-names> </name><name name-style="western"><surname>Kehail</surname><given-names>LS</given-names> </name><name name-style="western"><surname>Kamal</surname><given-names>RA</given-names> </name></person-group><article-title>Knowledge, attitudes, and practices of healthcare workers towards COVID-19 patients in the United Arab Emirates: a cross-sectional study</article-title><source>BMC Health Serv Res</source><year>2023</year><month>03</month><day>14</day><volume>23</volume><issue>1</issue><fpage>252</fpage><pub-id pub-id-type="doi">10.1186/s12913-023-09215-y</pub-id><pub-id pub-id-type="medline">36918937</pub-id></nlm-citation></ref><ref id="ref9"><label>9</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kunno</surname><given-names>J</given-names> </name><name name-style="western"><surname>Yubonpunt</surname><given-names>P</given-names> </name><name name-style="western"><surname>Supawattanabodee</surname><given-names>B</given-names> </name><name name-style="western"><surname>Wiriyasirivaj</surname><given-names>B</given-names> </name><name name-style="western"><surname>Sumanasrethakul</surname><given-names>C</given-names> </name></person-group><article-title>Covid-19 knowledge, attitudes, and practices among healthcare workers in urban community Bangkok, Thailand</article-title><source>Rocz Panstw Zakl Hig</source><year>2022</year><volume>73</volume><issue>1</issue><fpage>17</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.32394/rpzh.2022.0200</pub-id><pub-id pub-id-type="medline">35322955</pub-id></nlm-citation></ref><ref id="ref10"><label>10</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>Q</given-names> </name><name name-style="western"><surname>Yu</surname><given-names>C</given-names> </name><name name-style="western"><surname>Zheng</surname><given-names>Z</given-names> </name><etal/></person-group><article-title>Knowledge, attitude, and practices on COVID-19 prevention and diagnosis among medical workers in the radiology department: a multicenter cross-sectional study in China</article-title><source>Front Public Health</source><year>2023</year><volume>11</volume><fpage>1110893</fpage><pub-id pub-id-type="doi">10.3389/fpubh.2023.1110893</pub-id><pub-id pub-id-type="medline">36935704</pub-id></nlm-citation></ref><ref id="ref11"><label>11</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>J</given-names> </name><name name-style="western"><surname>Liao</surname><given-names>Y</given-names> </name><name name-style="western"><surname>Hua</surname><given-names>Q</given-names> </name><name name-style="western"><surname>Sun</surname><given-names>C</given-names> </name><name name-style="western"><surname>Lv</surname><given-names>H</given-names> </name></person-group><article-title>Knowledge, attitudes, and practices toward COVID-19: a cross-sectional study during normal management of the epidemic in China</article-title><source>Front Public Health</source><year>2022</year><month>09</month><day>8</day><volume>10</volume><fpage>913478</fpage><pub-id pub-id-type="doi">10.3389/fpubh.2022.913478</pub-id><pub-id pub-id-type="medline">36159311</pub-id></nlm-citation></ref><ref id="ref12"><label>12</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hawary</surname><given-names>NUM</given-names> </name><name name-style="western"><surname>Warif</surname><given-names>NMA</given-names> </name><name name-style="western"><surname>Ishak</surname><given-names>I</given-names> </name><etal/></person-group><article-title>Knowledge, attitude and practices associated with COVID-19 among undergraduate students from Malaysian public universities during the endemic phase: a cross-sectional study</article-title><source>BMC Public Health</source><year>2025</year><month>01</month><day>9</day><volume>25</volume><issue>1</issue><fpage>119</fpage><pub-id pub-id-type="doi">10.1186/s12889-024-19834-7</pub-id><pub-id pub-id-type="medline">39789525</pub-id></nlm-citation></ref><ref id="ref13"><label>13</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mohamadian</surname><given-names>H</given-names> </name><name name-style="western"><surname>Faraji</surname><given-names>A</given-names> </name><name name-style="western"><surname>Ghorrabi</surname><given-names>AT</given-names> </name><name name-style="western"><surname>Ghobadi-Dashdebi</surname><given-names>K</given-names> </name><name name-style="western"><surname>Salahshouri</surname><given-names>A</given-names> </name></person-group><article-title>The COVID-19 pandemic: knowledge, attitudes and practices of coronavirus (COVID-19) among patients with type 2 diabetes</article-title><source>J Health Popul Nutr</source><year>2023</year><month>02</month><day>20</day><volume>42</volume><issue>1</issue><fpage>11</fpage><pub-id pub-id-type="doi">10.1186/s41043-023-00349-7</pub-id><pub-id pub-id-type="medline">36805712</pub-id></nlm-citation></ref><ref id="ref14"><label>14</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rahman</surname><given-names>MM</given-names> </name><name name-style="western"><surname>Sakib</surname><given-names>MS</given-names> </name><name name-style="western"><surname>Rahman</surname><given-names>AS</given-names> </name><name name-style="western"><surname>Haque</surname><given-names>MI</given-names> </name><name name-style="western"><surname>Hossain</surname><given-names>MT</given-names> </name><name name-style="western"><surname>Islam</surname><given-names>MR</given-names> </name></person-group><article-title>Knowledge, attitude and practices towards COVID-19 among social workers of Bangladesh</article-title><source>Public Organ Rev</source><year>2023</year><month>06</month><volume>23</volume><issue>2</issue><fpage>493</fpage><lpage>514</lpage><pub-id pub-id-type="doi">10.1007/s11115-022-00679-w</pub-id></nlm-citation></ref><ref id="ref15"><label>15</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sirat</surname><given-names>R</given-names> </name><name name-style="western"><surname>Sahrai</surname><given-names>MS</given-names> </name><name name-style="western"><surname>Rahimi</surname><given-names>BA</given-names> </name><name name-style="western"><surname>Asady</surname><given-names>A</given-names> </name><name name-style="western"><surname>Wasiq</surname><given-names>AW</given-names> </name></person-group><article-title>Knowledge, attitudes and practices of university students toward COVID-19 in southern region, Afghanistan: a cross-sectional study</article-title><source>BMC Med Educ</source><year>2023</year><month>03</month><day>20</day><volume>23</volume><issue>1</issue><fpage>171</fpage><pub-id pub-id-type="doi">10.1186/s12909-023-04164-w</pub-id><pub-id pub-id-type="medline">36941657</pub-id></nlm-citation></ref><ref id="ref16"><label>16</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bekele</surname><given-names>F</given-names> </name><name name-style="western"><surname>Sheleme</surname><given-names>T</given-names> </name><name name-style="western"><surname>Fekadu</surname><given-names>G</given-names> </name><name name-style="western"><surname>Bekele</surname><given-names>K</given-names> </name></person-group><article-title>Patterns and associated factors of COVID-19 knowledge, attitude, and practice among general population and health care workers: a systematic review</article-title><source>SAGE Open Med</source><year>2020</year><volume>8</volume><fpage>2050312120970721</fpage><pub-id pub-id-type="doi">10.1177/2050312120970721</pub-id><pub-id pub-id-type="medline">33240497</pub-id></nlm-citation></ref><ref id="ref17"><label>17</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rehman</surname><given-names>AU</given-names> </name><name name-style="western"><surname>Tasleem</surname><given-names>Z</given-names> </name><name name-style="western"><surname>Muhammad</surname><given-names>SA</given-names> </name><etal/></person-group><article-title>Pattern and associated factors of COVID-19 knowledge, attitude and practice (KAP) among COVID-19-comorbid patients: a systematic review and meta-analysis</article-title><source>Front Public Health</source><year>2024</year><volume>12</volume><fpage>1365744</fpage><pub-id pub-id-type="doi">10.3389/fpubh.2024.1365744</pub-id><pub-id pub-id-type="medline">39494082</pub-id></nlm-citation></ref><ref id="ref18"><label>18</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barzegar</surname><given-names>M</given-names> </name><name name-style="western"><surname>Mirmosayyeb</surname><given-names>O</given-names> </name><name name-style="western"><surname>Gajarzadeh</surname><given-names>M</given-names> </name><etal/></person-group><article-title>COVID-19 among patients with multiple sclerosis: a systematic review</article-title><source>Neurol Neuroimmunol Neuroinflamm</source><year>2021</year><volume>8</volume><issue>4</issue><fpage>e1001</fpage><pub-id pub-id-type="doi">10.1212/NXI.0000000000001001</pub-id><pub-id pub-id-type="medline">34016734</pub-id></nlm-citation></ref><ref id="ref19"><label>19</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sahraian</surname><given-names>MA</given-names> </name><name name-style="western"><surname>Gheini</surname><given-names>MR</given-names> </name><name name-style="western"><surname>Rezaeimanesh</surname><given-names>N</given-names> </name><name name-style="western"><surname>Ghajarzadeh</surname><given-names>M</given-names> </name><name name-style="western"><surname>Naser Moghadasi</surname><given-names>A</given-names> </name></person-group><article-title>Knowledge regarding COVID-19 pandemic in patients with multiple sclerosis (MS): a report from Iran</article-title><source>Mult Scler Relat Disord</source><year>2020</year><month>07</month><volume>42</volume><fpage>102193</fpage><pub-id pub-id-type="doi">10.1016/j.msard.2020.102193</pub-id><pub-id pub-id-type="medline">32420011</pub-id></nlm-citation></ref><ref id="ref20"><label>20</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prasad Singh</surname><given-names>J</given-names> </name><name name-style="western"><surname>Sewda</surname><given-names>A</given-names> </name><name name-style="western"><surname>Shiv</surname><given-names>DG</given-names> </name></person-group><article-title>Assessing the knowledge, attitude and practices of students regarding the COVID-19 pandemic</article-title><source>J Health Manag</source><year>2020</year><volume>22</volume><issue>2</issue><fpage>281</fpage><lpage>290</lpage><pub-id pub-id-type="doi">10.1177/0972063420935669</pub-id></nlm-citation></ref><ref id="ref21"><label>21</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patwary</surname><given-names>MM</given-names> </name><name name-style="western"><surname>Hossain</surname><given-names>MR</given-names> </name><name name-style="western"><surname>Sultana</surname><given-names>R</given-names> </name><etal/></person-group><article-title>Knowledge, attitudes and practices of healthcare professionals toward the novel coronavirus during the early stage of COVID-19 in a lower-and-middle income country, Bangladesh</article-title><source>Front Public Health</source><year>2022</year><volume>10</volume><fpage>988063</fpage><pub-id pub-id-type="doi">10.3389/fpubh.2022.988063</pub-id><pub-id pub-id-type="medline">36187704</pub-id></nlm-citation></ref><ref id="ref22"><label>22</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kumar</surname><given-names>J</given-names> </name><name name-style="western"><surname>Katto</surname><given-names>MS</given-names> </name><name name-style="western"><surname>Siddiqui</surname><given-names>AA</given-names> </name><etal/></person-group><article-title>Knowledge, attitude, and practices of healthcare workers regarding the use of face mask to limit the spread of the new coronavirus disease (COVID-19)</article-title><source>Cureus</source><year>2020</year><month>04</month><day>20</day><volume>12</volume><issue>4</issue><fpage>e7737</fpage><pub-id pub-id-type="doi">10.7759/cureus.7737</pub-id><pub-id pub-id-type="medline">32455057</pub-id></nlm-citation></ref><ref id="ref23"><label>23</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kamate</surname><given-names>SK</given-names> </name><name name-style="western"><surname>Sharma</surname><given-names>S</given-names> </name><name name-style="western"><surname>Thakar</surname><given-names>S</given-names> </name><etal/></person-group><article-title>Assessing knowledge, attitudes and practices of dental practitioners regarding the COVID-19 pandemic: a multinational study</article-title><source>Dent Med Probl</source><year>2020</year><volume>57</volume><issue>1</issue><fpage>11</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.17219/dmp/119743</pub-id><pub-id pub-id-type="medline">32307930</pub-id></nlm-citation></ref><ref id="ref24"><label>24</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>AlRasheed</surname><given-names>MM</given-names> </name><name name-style="western"><surname>AlShahrani</surname><given-names>AH</given-names> </name><name name-style="western"><surname>AlMuhaini</surname><given-names>SA</given-names> </name><etal/></person-group><article-title>Knowledge, attitude, and practice towards COVID-19 among pharmacists: a cross-sectional study</article-title><source>Risk Manag Healthc Policy</source><year>2021</year><volume>14</volume><fpage>3079</fpage><lpage>3090</lpage><pub-id pub-id-type="doi">10.2147/RMHP.S317779</pub-id><pub-id pub-id-type="medline">34326673</pub-id></nlm-citation></ref><ref id="ref25"><label>25</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Parikh</surname><given-names>PA</given-names> </name><name name-style="western"><surname>Shah</surname><given-names>BV</given-names> </name><name name-style="western"><surname>Phatak</surname><given-names>AG</given-names> </name><etal/></person-group><article-title>COVID-19 pandemic: knowledge and perceptions of the public and healthcare professionals</article-title><source>Cureus</source><year>2020</year><month>05</month><day>15</day><volume>12</volume><issue>5</issue><fpage>e8144</fpage><pub-id pub-id-type="doi">10.7759/cureus.8144</pub-id><pub-id pub-id-type="medline">32550063</pub-id></nlm-citation></ref><ref id="ref26"><label>26</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Masoud</surname><given-names>AT</given-names> </name><name name-style="western"><surname>Zaazouee</surname><given-names>MS</given-names> </name><name name-style="western"><surname>Elsayed</surname><given-names>SM</given-names> </name><etal/></person-group><article-title>KAP-COVID<sub>GLOBAL</sub>: a multinational survey of the levels and determinants of public knowledge, attitudes and practices towards COVID-19</article-title><source>BMJ Open</source><year>2021</year><month>02</month><day>23</day><volume>11</volume><issue>2</issue><fpage>e043971</fpage><pub-id pub-id-type="doi">10.1136/bmjopen-2020-043971</pub-id><pub-id pub-id-type="medline">33622949</pub-id></nlm-citation></ref><ref id="ref27"><label>27</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luo</surname><given-names>YF</given-names> </name><name name-style="western"><surname>Chen</surname><given-names>LC</given-names> </name><name name-style="western"><surname>Yang</surname><given-names>SC</given-names> </name><name name-style="western"><surname>Hong</surname><given-names>S</given-names> </name></person-group><article-title>Knowledge, attitude, and practice (KAP) toward COVID-19 pandemic among the public in Taiwan: a cross-sectional study</article-title><source>Int J Environ Res Public Health</source><year>2022</year><month>02</month><day>27</day><volume>19</volume><issue>5</issue><fpage>2784</fpage><pub-id pub-id-type="doi">10.3390/ijerph19052784</pub-id><pub-id pub-id-type="medline">35270491</pub-id></nlm-citation></ref><ref id="ref28"><label>28</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gao</surname><given-names>H</given-names> </name><name name-style="western"><surname>Hu</surname><given-names>R</given-names> </name><name name-style="western"><surname>Yin</surname><given-names>L</given-names> </name><etal/></person-group><article-title>Knowledge, attitudes and practices of the Chinese public with respect to coronavirus disease (COVID-19): an online cross-sectional survey</article-title><source>BMC Public Health</source><year>2020</year><month>11</month><day>30</day><volume>20</volume><issue>1</issue><fpage>1816</fpage><pub-id pub-id-type="doi">10.1186/s12889-020-09961-2</pub-id><pub-id pub-id-type="medline">33256707</pub-id></nlm-citation></ref><ref id="ref29"><label>29</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dardas</surname><given-names>LA</given-names> </name><name name-style="western"><surname>Khalaf</surname><given-names>I</given-names> </name><name name-style="western"><surname>Nabolsi</surname><given-names>M</given-names> </name><name name-style="western"><surname>Nassar</surname><given-names>O</given-names> </name><name name-style="western"><surname>Halasa</surname><given-names>S</given-names> </name></person-group><article-title>Developing an understanding of adolescents' knowledge, attitudes, and practices toward COVID-19</article-title><source>J Sch Nurs</source><year>2020</year><month>12</month><volume>36</volume><issue>6</issue><fpage>430</fpage><lpage>441</lpage><pub-id pub-id-type="doi">10.1177/1059840520957069</pub-id><pub-id pub-id-type="medline">32990150</pub-id></nlm-citation></ref><ref id="ref30"><label>30</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhong</surname><given-names>BL</given-names> </name><name name-style="western"><surname>Luo</surname><given-names>W</given-names> </name><name name-style="western"><surname>Li</surname><given-names>HM</given-names> </name><etal/></person-group><article-title>Knowledge, attitudes, and practices towards COVID-19 among Chinese residents during the rapid rise period of the COVID-19 outbreak: a quick online cross-sectional survey</article-title><source>Int J Biol Sci</source><year>2020</year><volume>16</volume><issue>10</issue><fpage>1745</fpage><lpage>1752</lpage><pub-id pub-id-type="doi">10.7150/ijbs.45221</pub-id><pub-id pub-id-type="medline">32226294</pub-id></nlm-citation></ref><ref id="ref31"><label>31</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>K</given-names> </name><name name-style="western"><surname>Liu</surname><given-names>H</given-names> </name><name name-style="western"><surname>Ma</surname><given-names>L</given-names> </name><etal/></person-group><article-title>Knowledge, attitude and practice of residents in the prevention and control of COVID-19: an online questionnaire survey</article-title><source>J Adv Nurs</source><year>2021</year><month>04</month><volume>77</volume><issue>4</issue><fpage>1839</fpage><lpage>1855</lpage><pub-id pub-id-type="doi">10.1111/jan.14718</pub-id><pub-id pub-id-type="medline">33259651</pub-id></nlm-citation></ref><ref id="ref32"><label>32</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Azlan</surname><given-names>AA</given-names> </name><name name-style="western"><surname>Hamzah</surname><given-names>MR</given-names> </name><name name-style="western"><surname>Sern</surname><given-names>TJ</given-names> </name><name name-style="western"><surname>Ayub</surname><given-names>SH</given-names> </name><name name-style="western"><surname>Mohamad</surname><given-names>E</given-names> </name></person-group><article-title>Public knowledge, attitudes and practices towards COVID-19: a cross-sectional study in Malaysia</article-title><source>PLoS One</source><year>2020</year><volume>15</volume><issue>5</issue><fpage>e0233668</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0233668</pub-id><pub-id pub-id-type="medline">32437434</pub-id></nlm-citation></ref><ref id="ref33"><label>33</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alsomali</surname><given-names>N</given-names> </name><name name-style="western"><surname>Amer</surname><given-names>KA</given-names> </name><name name-style="western"><surname>Almutairi</surname><given-names>AA</given-names> </name><etal/></person-group><article-title>Assessment of multiple sclerosis patients&#x2019; knowledge and behavioral practice regarding COVID-19 in Saudi Arabia</article-title><source>Cureus</source><year>2022</year><month>12</month><volume>14</volume><issue>12</issue><fpage>e32781</fpage><pub-id pub-id-type="doi">10.7759/cureus.32781</pub-id><pub-id pub-id-type="medline">36686104</pub-id></nlm-citation></ref><ref id="ref34"><label>34</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>L</given-names> </name><name name-style="western"><surname>Liu</surname><given-names>YP</given-names> </name><name name-style="western"><surname>Wang</surname><given-names>J</given-names> </name><name name-style="western"><surname>An</surname><given-names>LW</given-names> </name><name name-style="western"><surname>Jiao</surname><given-names>JM</given-names> </name></person-group><article-title>Use of a knowledge-attitude-behaviour education programme for Chinese adults undergoing maintenance haemodialysis: randomized controlled trial</article-title><source>J Int Med Res</source><year>2016</year><month>06</month><volume>44</volume><issue>3</issue><fpage>557</fpage><lpage>568</lpage><pub-id pub-id-type="doi">10.1177/0300060515604980</pub-id><pub-id pub-id-type="medline">26951842</pub-id></nlm-citation></ref><ref id="ref35"><label>35</label><nlm-citation citation-type="confproc"><person-group person-group-type="author"><name name-style="western"><surname>Bin Zulkifli</surname><given-names>AZ</given-names> </name><name name-style="western"><surname>Yeter</surname><given-names>IH</given-names> </name><name name-style="western"><surname>Ali</surname><given-names>F</given-names> </name></person-group><article-title>Examining k-12 Singaporean parents&#x2019; engineering awareness: an initial study of the knowledge, attitude, and behavior (KAB) framework (fundamental)</article-title><conf-name>2022 ASEE Annual Conference &#x0026; Exposition</conf-name><conf-date>Jun 26-29, 2022</conf-date><pub-id pub-id-type="doi">10.18260/1-2--41196</pub-id></nlm-citation></ref><ref id="ref36"><label>36</label><nlm-citation citation-type="other"><person-group person-group-type="author"><name name-style="western"><surname>Maleki</surname><given-names>S</given-names> </name><name name-style="western"><surname>Najafi</surname><given-names>F</given-names> </name><name name-style="western"><surname>Farhadi</surname><given-names>K</given-names> </name><name name-style="western"><surname>Fakhri</surname><given-names>M</given-names> </name><name name-style="western"><surname>Hosseini</surname><given-names>F</given-names> </name><name name-style="western"><surname>Naderi</surname><given-names>M</given-names> </name></person-group><article-title>Knowledge, attitude and behavior of health care workers in the prevention of COVID-19</article-title><source>Research Square</source><comment>Preprint posted online on  Apr 25, 2020</comment><pub-id pub-id-type="doi">10.21203/rs.3.rs-23113/v1</pub-id></nlm-citation></ref><ref id="ref37"><label>37</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Winters</surname><given-names>M</given-names> </name><name name-style="western"><surname>Jalloh</surname><given-names>MF</given-names> </name><name name-style="western"><surname>Sengeh</surname><given-names>P</given-names> </name><etal/></person-group><article-title>Risk communication and ebola-specific knowledge and behavior during 2014&#x2013;2015 outbreak, Sierra Leone</article-title><source>Emerg Infect Dis</source><year>2018</year><month>02</month><volume>24</volume><issue>2</issue><fpage>336</fpage><lpage>344</lpage><pub-id pub-id-type="doi">10.3201/eid2402.171028</pub-id><pub-id pub-id-type="medline">29350151</pub-id></nlm-citation></ref><ref id="ref38"><label>38</label><nlm-citation citation-type="web"><article-title>CDC and partners use data-driven communication interventions to fight ebola</article-title><source>Centers for Disease Control and Prevention</source><access-date>2024-12-30</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://archive.cdc.gov/www_cdc_gov/globalhealth/stories/data-driven-comm.html">https://archive.cdc.gov/www_cdc_gov/globalhealth/stories/data-driven-comm.html</ext-link></comment></nlm-citation></ref><ref id="ref39"><label>39</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qalati</surname><given-names>SA</given-names> </name><name name-style="western"><surname>Ostic</surname><given-names>D</given-names> </name><name name-style="western"><surname>Fan</surname><given-names>M</given-names> </name><etal/></person-group><article-title>The general public knowledge, attitude, and practices regarding COVID-19 during the lockdown in Asian developing countries</article-title><source>Community Health Equity Res Policy</source><year>2023</year><month>04</month><volume>43</volume><issue>3</issue><fpage>239</fpage><lpage>248</lpage><pub-id pub-id-type="doi">10.1177/0272684X211004945</pub-id><pub-id pub-id-type="medline">33832371</pub-id></nlm-citation></ref><ref id="ref40"><label>40</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Seninde</surname><given-names>DR</given-names> </name><name name-style="western"><surname>Chambers</surname><given-names>E</given-names>  <suffix>4th</suffix></name></person-group><article-title>Comparing the rate-all-that-apply and rate-all-statements question formats across five countries</article-title><source>Foods</source><year>2021</year><month>03</month><day>25</day><volume>10</volume><issue>4</issue><fpage>702</fpage><pub-id pub-id-type="doi">10.3390/foods10040702</pub-id><pub-id pub-id-type="medline">33806134</pub-id></nlm-citation></ref><ref id="ref41"><label>41</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smyth</surname><given-names>JD</given-names> </name><name name-style="western"><surname>Dillman</surname><given-names>DA</given-names> </name><name name-style="western"><surname>Christian</surname><given-names>LM</given-names> </name><name name-style="western"><surname>Stern</surname><given-names>MJ</given-names> </name></person-group><article-title>Comparing check-all and forced-choice question formats in web surveys</article-title><source>Public Opin Q</source><year>2006</year><volume>70</volume><issue>1</issue><fpage>66</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1093/poq/nfj007</pub-id></nlm-citation></ref><ref id="ref42"><label>42</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Braun</surname><given-names>V</given-names> </name><name name-style="western"><surname>Clarke</surname><given-names>V</given-names> </name></person-group><article-title>Using thematic analysis in psychology</article-title><source>Qual Res Psychol</source><year>2006</year><volume>3</volume><issue>2</issue><fpage>77</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1191/1478088706qp063oa</pub-id></nlm-citation></ref><ref id="ref43"><label>43</label><nlm-citation citation-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Braun</surname><given-names>V</given-names> </name><name name-style="western"><surname>Clarke</surname><given-names>V</given-names> </name></person-group><source>Thematic Analysis: A Practical Guide</source><year>2021</year><publisher-name>SAGE publications</publisher-name><pub-id pub-id-type="other">9781526417305</pub-id></nlm-citation></ref><ref id="ref44"><label>44</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Braun</surname><given-names>V</given-names> </name><name name-style="western"><surname>Clarke</surname><given-names>V</given-names> </name></person-group><article-title>Conceptual and design thinking for thematic analysis</article-title><source>Qual Psychol</source><year>2022</year><volume>9</volume><issue>1</issue><fpage>3</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1037/qup0000196</pub-id></nlm-citation></ref><ref id="ref45"><label>45</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Braun</surname><given-names>V</given-names> </name><name name-style="western"><surname>Clarke</surname><given-names>V</given-names> </name></person-group><article-title>Toward good practice in thematic analysis: avoiding common problems and be(com)ing a knowing researcher</article-title><source>Int J Transgend Health</source><year>2023</year><volume>24</volume><issue>1</issue><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1080/26895269.2022.2129597</pub-id><pub-id pub-id-type="medline">36713144</pub-id></nlm-citation></ref><ref id="ref46"><label>46</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group><article-title>Naming the coronavirus disease (COVID-19) and the virus that causes it</article-title><source>Braz J Implantol Health Sci</source><year>2020</year><access-date>2026-04-21</access-date><volume>2</volume><issue>3</issue><comment><ext-link ext-link-type="uri" xlink:href="https://bjihs.emnuvens.com.br/bjihs/article/view/173">https://bjihs.emnuvens.com.br/bjihs/article/view/173</ext-link></comment></nlm-citation></ref><ref id="ref47"><label>47</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group><article-title>The corona virus disease 2019 (COVID-19)</article-title><source>Braz J Implantol Health Sci</source><year>2022</year><access-date>2026-04-21</access-date><volume>4</volume><issue>6</issue><fpage>45</fpage><lpage>46</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://bjihs.emnuvens.com.br/bjihs/article/view/226">https://bjihs.emnuvens.com.br/bjihs/article/view/226</ext-link></comment></nlm-citation></ref><ref id="ref48"><label>48</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>M</given-names> </name><name name-style="western"><surname>Kang</surname><given-names>BA</given-names> </name><name name-style="western"><surname>You</surname><given-names>M</given-names> </name></person-group><article-title>Knowledge, attitudes, and practices (KAP) toward COVID-19: a cross-sectional study in South Korea</article-title><source>BMC Public Health</source><year>2021</year><volume>21</volume><issue>1</issue><fpage>295</fpage><pub-id pub-id-type="doi">10.1186/s12889-021-10285-y</pub-id></nlm-citation></ref><ref id="ref49"><label>49</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cipolletta</surname><given-names>S</given-names> </name><name name-style="western"><surname>Andreghetti</surname><given-names>GR</given-names> </name><name name-style="western"><surname>Mioni</surname><given-names>G</given-names> </name></person-group><article-title>Risk perception towards COVID-19: a systematic review and qualitative synthesis</article-title><source>Int J Environ Res Public Health</source><year>2022</year><month>04</month><day>12</day><volume>19</volume><issue>8</issue><fpage>4649</fpage><pub-id pub-id-type="doi">10.3390/ijerph19084649</pub-id><pub-id pub-id-type="medline">35457521</pub-id></nlm-citation></ref><ref id="ref50"><label>50</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names> </name><name name-style="western"><surname>Staker</surname><given-names>E</given-names> </name><name name-style="western"><surname>Cutter</surname><given-names>G</given-names> </name><name name-style="western"><surname>Krieger</surname><given-names>S</given-names> </name><name name-style="western"><surname>Miller</surname><given-names>AE</given-names> </name></person-group><article-title>Perceptions of risk and adherence to care in MS patients during the COVID-19 pandemic: a cross-sectional study</article-title><source>Mult Scler Relat Disord</source><year>2021</year><month>05</month><volume>50</volume><fpage>102856</fpage><pub-id pub-id-type="doi">10.1016/j.msard.2021.102856</pub-id><pub-id pub-id-type="medline">33662858</pub-id></nlm-citation></ref><ref id="ref51"><label>51</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ehde</surname><given-names>DM</given-names> </name><name name-style="western"><surname>Roberts</surname><given-names>MK</given-names> </name><name name-style="western"><surname>Humbert</surname><given-names>AT</given-names> </name><name name-style="western"><surname>Herring</surname><given-names>TE</given-names> </name><name name-style="western"><surname>Alschuler</surname><given-names>KN</given-names> </name></person-group><article-title>COVID-19 vaccine hesitancy in adults with multiple sclerosis in the United States: a follow up survey during the initial vaccine rollout in 2021</article-title><source>Mult Scler Relat Disord</source><year>2021</year><month>09</month><volume>54</volume><fpage>103163</fpage><pub-id pub-id-type="doi">10.1016/j.msard.2021.103163</pub-id><pub-id pub-id-type="medline">34325399</pub-id></nlm-citation></ref><ref id="ref52"><label>52</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cadwgan</surname><given-names>J</given-names> </name><name name-style="western"><surname>Goodwin</surname><given-names>J</given-names> </name><name name-style="western"><surname>Arichi</surname><given-names>T</given-names> </name><etal/></person-group><article-title>Care in COVID: a qualitative analysis of the impact of COVID&#x2010;19 on the health and care of children and young people with severe physical neurodisability and their families</article-title><source>Child Care Health Dev</source><year>2022</year><month>11</month><volume>48</volume><issue>6</issue><fpage>924</fpage><lpage>934</lpage><pub-id pub-id-type="doi">10.1111/cch.12925</pub-id><pub-id pub-id-type="medline">34773287</pub-id></nlm-citation></ref><ref id="ref53"><label>53</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mejdahl</surname><given-names>CT</given-names> </name><name name-style="western"><surname>Nielsen</surname><given-names>PB</given-names> </name><name name-style="western"><surname>Nielsen</surname><given-names>LA</given-names> </name><name name-style="western"><surname>Christensen</surname><given-names>AF</given-names> </name><name name-style="western"><surname>Nielsen</surname><given-names>BK</given-names> </name></person-group><article-title>Experiences of being at high-risk during the COVID-19 pandemic and its impact on emotional well-being and daily life in people with chronic conditions: a qualitative study</article-title><source>J Patient Rep Outcomes</source><year>2023</year><month>07</month><day>5</day><volume>7</volume><issue>1</issue><fpage>62</fpage><pub-id pub-id-type="doi">10.1186/s41687-023-00607-6</pub-id><pub-id pub-id-type="medline">37405541</pub-id></nlm-citation></ref><ref id="ref54"><label>54</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>N&#x00F6;stlinger</surname><given-names>C</given-names> </name><name name-style="western"><surname>Van Landeghem</surname><given-names>E</given-names> </name><name name-style="western"><surname>Vanhamel</surname><given-names>J</given-names> </name><etal/></person-group><article-title>COVID-19 as a social disease: qualitative analysis of COVID-19 prevention needs, impact of control measures and community responses among racialized/ethnic minorities in Antwerp, Belgium</article-title><source>Int J Equity Health</source><year>2022</year><month>05</month><day>16</day><volume>21</volume><issue>1</issue><fpage>67</fpage><pub-id pub-id-type="doi">10.1186/s12939-022-01672-x</pub-id><pub-id pub-id-type="medline">35578292</pub-id></nlm-citation></ref><ref id="ref55"><label>55</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>DeSalvo</surname><given-names>K</given-names> </name><name name-style="western"><surname>Hughes</surname><given-names>B</given-names> </name><name name-style="western"><surname>Bassett</surname><given-names>M</given-names> </name><etal/></person-group><article-title>Public health COVID-19 impact assessment: lessons learned and compelling needs</article-title><source>NAM Perspect</source><year>2021</year><volume>2021</volume><pub-id pub-id-type="doi">10.31478/202104c</pub-id><pub-id pub-id-type="medline">34532688</pub-id></nlm-citation></ref></ref-list></back></article>